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Abstract 
The allostatic load model represents an interdisciplinary approach to comprehensively 
conceptualize and quantify chronic stress in relation to pathologies throughout the life cycle. This 
article first reviews the allostatic load model, followed by interactions among early adversity, 
genetics, environmental toxins, as well as distinctions among sex, gender, and sex hormones as 
integral antecedents of allostatic load. We next explore perspectives on severe mental illness, 
dementia, and caregiving as unique human models of allostatic load that merit future 
investigations in the field of developmental psychopathology. A complimenting transdisciplinary 
perspective is applied throughout, whereby we argue that the allostatic load model goes beyond 
traditional stress-disease theories towards the advancement of person-centered research and 
practice that promote not only physical health but also mental health. 
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Introduction 
Stress researchers require interdisciplinary frameworks to study the effects and 
consequences of chronic stress. One major obstacle in understanding and defining stress is that it 
is a multidimensional construct involving interactions among inputs (environmental stressors), 
processes (subjective psychological distress), and outputs (objective biological stress responses) 
(Levine, 2005; Levine & Ursin, 1991) that are often investigated separately from each other. Over 
the last two decades, the concepts of allostasis (Sterling & Eyer, 1988) and of allostatic load 
(McEwen & Stellar, 1993) have served as the impetus for hundreds of publications that go far 
beyond the perspective that “stress” is an exclusively social, psychological, or biological 
construct, but rather all constructs studied together in an integrative framework (for an earlier 
review, see (Lupien et al., 2006). 
Originating as a biopsychosocial model, allostatic load (AL) refers to the ‘wear and tear’ 
the body experiences when organisms are subjugated to chronic stress. Central to this biological 
damage is altered stress hormone functioning that inexorably strains interconnected biomarkers 
that eventually collapse like domino pieces trailing towards stress-related endpoints. The 
traditional operational definition of the AL index is the sum number of dysregulated 
neuroendocrine, immune, metabolic, and cardiovascular biomarkers (Seeman, Singer, Rowe, 
Horwitz, & McEwen, 1997a). This aggregate or AL index has then been used to tease apart the 
psychosocial determinants of disordered, diseased, and deceased outcomes. An emerging body of 
literature clearly demonstrates that the AL index is associated with numerous physical outcomes 
throughout lifespan development and even psychopathological outcomes (for an earlier review, 
see Juster, McEwen, & Lupien, 2010). 
With the aim of refining the AL model further in application to psychopathological 
phenomena throughout the life cycle, we offer the following review of the causes and effects of 
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AL. The first part of this article will review literature on powerful antecedents of AL: (a) early 
adversity that predisposes individuals to life-long disease susceptibilities; (b) genetic and 
epigenetic factors; (c) mediation or moderation by environmental toxins; as well as (d) 
interactions among biological sex, socio-cultural gender, and sex hormones. We follow secondly 
with an exploration of pathophysiological manifestations that could be used as human models of 
AL: (e) living with schizophrenia or bipolar disorder; (f) the dementia spectrum; and finally (g) 
the experience of caregiving. Our hope is to transcend the boundaries of existing theory, research, 
and practice by proposing that the AL model can evolve into a transdisciplinary framework that 
ushers a holistic approach to understand and help distressed individuals. Sharing key similarities 
with developmental psychopathological models, a transdisciplinary AL model likewise would 
seek to address the causes, mechanisms, and heterogeniety manifested among diverse stress-
related disease trajectories. 
Transdisciplinarity is an approach to scientific inquiry aimed at solving complex research 
questions by transcending traditional disciplinary boundaries (Kessel & Rosenfield, 2008; 
Rosenfield, 1992). The complexities inherent among numerous interacting factors that contribute 
to an individual’s experience of health or disease necessarily calls for transdisciplinary models 
that do more than integrate knowledge (Albrecht, Freeman, & Higginbotham, 1998; Kessel, 
Rosenfield, & Anderson, 2008). In transdisciplinary health models, our concepts of health can 
evolve beyond the absence of disease, and even beyond the sum of biopsychosocial parts towards 
more holistic ones.  
In this view, health is an emergent property of individuals taken as a whole (Picard, 
Sabiston, & McNamara, 2011) (see Figure 1). Indeed, all factors discussed throughout this review 
interact in unique ways to influence one’s risk of or protection against the noxious effects of 
chronic stress. In this spirit, we encourage the reader to contextualize the presented information 
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within their respective area(s) of expertise in partnership with others and especially vis-à-vis 
complementary perspectives espoused in the field of developmental psycholopathology.  
Briefly, the defining features of developmental psychopathology are (1) understanding 
causal processes, (2) elucidating developmental mechanisms, and (3) emphasis on diverse 
conceptualizations of continuities and discontinuities between spectrums of normality and 
abnormality in mental health (Rutter & Sroufe, 2000). Such integrative perspectives focus on how 
multiple causes and effects contribute to probabilistic rather than deterministic pathways leading 
to diverse outcomes (Cichetti & Toth, 2009). In particular, ‘developmental analyses’ highlight the 
dynamic nature of individual differences in vulnerabilities and resiliencies shaped by interacting 
factors studied from the micro to maco level (Cichetti & Toth, 2009). The AL model shares much 
in this diverse spirit of analysis bridging numerous disciplines together. Yet, empirical 
substantiations of AL theory remain largely based on population-level analyses. 
Specifically, the AL model has been primarily applied to detect physical morbidities and 
all-cause mortality in epidemiological analyses. While promising, it has been challenging to 
propose applications towards more individual-level analyses pertinent to understanding complex 
psychopathological phenomena. Notable exceptions have emerged; however, there remains some 
resistance to extensively investigate AL in humans in the neurosciences, psychiatry, and 
psychology. To address this, our principal objectives in this article are twofold: 1) to review the 
AL model from a developmental psychopathology perspective in relation to current and future 
research areas; and 2) to outline transdisciplinary interactions between key AL factors and 
psychopathological conditions. We begin with a brief introduction of key terms and concepts. 
 
Stress and the neurobiology of stress responses 
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Stress is here defined as a real or interpreted threat to an individual’s physiological and 
psychological integrity that results in adaptive biological and behavioral responses (McEwen & 
Seeman, 1999). Situations that are novel, unpredictable, threatening to the ego/self, and/or 
uncontrollable additively contribute to physiological stress responses (Dickerson & Kemeny, 
2004; Lupien et al., 2006; Mason, 1968). Under these circumstances, stress responses are 
activated by the autonomic nervous system and neuroendocrine system to mobilize energy 
necessary to adapt to the demands of the situation (McEwen, 1998b; Sapolsky, Romero, & 
Munck, 2000).  
At first, perceived and interpreted threats trigger the sympathetic-adrenal-medullary 
(SAM) axis to release catecholamines (e.g., adrenalin) within seconds from the adrenal medulla 
surrounding the kidneys. Secondly, the hypothalamic-pituitary-adrenal (HPA) axis is activated 
within minutes to produce glucocorticoids. The hypothalamus activates the HPA-axis by 
stimulating corticotrophin-releasing factor (CRF). CRF then travels through a portal system 
linking the hypothalamus to the pituitary, where it signals the secretion of adrenocorticotrophin 
hormone (ACTH) from the anterior pituitary rich with blood capillaries. ACTH then travels 
viscerally to the adrenal cortex surrounding the kidneys where it binds to receptor tissue and 
precipitates cellular activities in the zona fasticullata region of the adrenal cortex to produce 
glucocorticoids (GCs) such as cortisol in humans (Sapolsky et al., 2000). The resulting surges in 
catecholamines and GCs alter homeostasis by appropriating biological functions that permit fight-
or-flight responses. 
The brain’s ultimate role during stress responses is to detect threat and adapt. In addition to 
the pituitary and hypothalamic activities, there are three major brain structures involved in the 
regulation of stress responses: (1) the hippocampus linked to memory and cognition, in addition to 
being implicated in negative feedback regulation of the HPA-axis; (2) the amygdala responsible 
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for fear conditioning and emotional processing with outputs to autonomic and neuroendocrine 
regulatory systems, and; (3) the prefrontal cortex involved in cognition and coping strategies and 
exerting top-down control over subcortical structures (Gray & Bingaman, 1996; McEwen, 2004; 
McEwen, Weiss, & Schwartz, 1968; Reul & de Kloet, 1985; Sanchez, Young, Plotsky, & Insel, 
2000; Thayer & Lane, 2009). In concert with the autonomic nervous system, short-term 
adaptations of organisms during stress responses are dynamic biological processes that ensure 
survival. 
 
Concept of allostasis 
SAM- and HPA-axis stress responses are examples of allostasis, defined as adaptive 
biological processes that preserve “stability through change” (Sterling & Eyer, 1988). This 
concept was coined by an epidemiologist and a neurobiologist to describe how the body maintains 
homeostasis by allocating metabolic energy to cope with the demands of the environment 
(Sterling, 2004). In contrast to homeostasis that focuses on static set-points (e.g., Ph levels, core 
body temperature), the concept of allostasis focuses on how continuous re-evaluation and re-
adjustments create new set-points that maximize the organism’s resources (e.g., increased cardiac 
output when running). Likewise, homeostatic mechanisms cannot adequately account for how the 
brain appropriates itself beyond rigidly enforced biological mechanisms. For instance, when 
increased needs create an error signal, negative feedback mechanisms may try to correct the error 
and cause more error (e.g., rapidly rising causing head-rush and dizziness). Allostasis can drive 
behaviors explaining how anticipation of physiological change can rectify these errors (e.g., 
getting up slowly to prevent dizziness) and in this way, considers an unusual parameter value not 
as a failure to defend a set-point, but rather as a response to some prediction (Sterling, 2004; 
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(Goldstein & Kopin, 2007). This perspective allows for a greater understanding of the relation 
between physiological needs, behavior, and pathology (Sterling & Eyer, 1988).  
Homeostatic models generally define health as an internal milieu whereby all 
physiological parameters have relatively normal values. Disease, on the other hand, occurs when 
normal ranges fall into abnormal but pharmaceutically correctable ranges. In this view, Sterling 
and Eyer (1988) argued that the medical model is in danger of iatrogenesis, that is, the deleterious 
effects that certain treatments can inadvertently induce. Iatrogenic effects can arise when restoring 
one parameter to a normal range causes other parameters to become “inappropriately” high or low 
and cause altogether separate health issues (e.g., hypertension medications can negatively alter 
interconnected biological systems). In contrast, the allostatic model defines health as a state of 
responsiveness. A parameter with values outside the normal range is not necessarily considered 
inappropriate as each parameter is controlled by a multitude of mutually reinforcing signals 
(Sterling, 2004).  
In summary, allostasis fundamentally differs from homeostasis because of its emphasis on 
dynamic rather than static biological set-points, considerations of the brain’s role in feedback 
regulation (for a review of allostasis and the brain, see (Ganzel, Morris, & Wethington, 2010), as 
well as its view of health as a whole-body adaptation to contexts (Schulkin, 2003b). According to 
allostatic theory, pathology itself is a form of adaptation where, for instance, an individual 
develops hypertension in order to conciliate environmental demands, even if these processes are 
pathophysiological. Health in allostatic theory is therefore defined as optimal predictive 
fluctuation, whereby shifts in the probability of demand should shift the response, and when the 
prediction reverses, so should the response (Sterling, 2004).  In this view, the allostasis concept is 
consistent with a transdisciplinary definition of health and disease emphasizing holistic 
relationships among individuals and environments. It is, however, when these adaptive systems 
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become chronically dysregulated that maladaptive physiological consequences emerge. The 
concept of allostasis therefore represents a multi-faceted mechanism of regulation applicable to 
psychopathological as well as pathophysiological research by uniting mind and body in 
explanations of dynamic stability that can go astray.  
 
The allostatic load model 
McEwen & Stellar (1993) expanded upon allostasis by proposing that AL is the price that 
the body incurs when bombarded by stressful situations and prolonged stress responses. The 
principal points of the AL model are twofold: (1) AL involves multiple interconnected biomarkers 
that can falter primarily as a function of stress hormone dysregulations, and that (2) the health 
sciences should not wait idly by for individuals to reach clinical levels on these biomarkers but 
should instead identify sub-clinical states before they lead to pathology.  
To substantiate these arguments, the AL model synthesizes a rich, interdisciplinary 
literature on stress and disease by elucidating how numerous factors converge to predispose 
individuals to stress-related pathologies over the life cycle (McEwen, 2000a). This endeavor 
necessitates fusion of multiple knowledge bases, as coordination of allostasis depends on the 
brain’s evaluation of threat and execution of physiological responses (Herman, Ostrander, 
Mueller, & Figueiredo, 2005; McEwen, 2007b, 2008). This coordination is fundamentally shaped 
by an individual’s constitution (genetics, development), history (trauma/abuse, major life events, 
early adversity), and behaviors (coping and health habits) (McEwen, 1998a). Akin to 
developmental psychopathological emphasis on how experiences can alter developmental 
pathways, understanding how these diverse factors are integrated at the individual level to yield 
altered expressions of normative functioning can provide innovative ways of treating ill 
individuals and fostering positive health.  
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In contrast to healthy allostatic responses whereby individuals react and recover to 
stressors effectively, allostatic states (Koob & Le Moal, 2001) can occur when chronic 
dysregulation of regulatory systems lead to pathophysiological operating ranges. There are four 
postulated physiological profiles that represent allostatic states that contribute to AL:  (1) 
repeatedly activated responses (2) non-habituating responses (3) prolonged responses, (4) and 
inadequate responses (McEwen, 1998a) (see Figure 2). Detecting these different allostatic states 
is possible by investigating biomarker(s) dynamics in transdisciplinary manner vis-à-vis health 
outcomes. Because allostatic states prompt compensatory remediation among numerous 
biomarkers, each of which is shaped by numerous factors, delineating time-courses of 
dysregulation in AL involves the challenge of determining which players falter first in the cascade 
(McEwen, 2008).  
Multiple biomarkers are hypothesized to function as part of a non-linear network that 
contributes to a tripartite sequence leading to AL (McEwen, 1998a). At first, over-activation of 
primary mediators such as stress hormones and pro- and anti-inflammatory cytokines exact 
primary effects on cellular functions such as enzyme, receptor, ion channel, and genomic 
activities. Synergistic effects of several primary mediators then leads to tissue and organ specific 
changes in several systems. Subsidiary systems in turn recalibrate their own activities to 
compensate for the over and/or under production of primary mediators and effects.  
This leads to secondary outcomes, whereby metabolic, cardiovascular, immune, and 
reproductive biomarkers become imbalanced. Multiple pathways interact in a non-linear fashion 
whereby oscillations in biomarker levels drive compensatory recalibrations of other intertwined 
biomarkers (see Figure 3). For example, inflammatory cytokine production is negatively 
regulated via anti-inflammatory cytokines as well as via parasympathetic and GC pathways, 
whereas sympathetic activity increases inflammatory cytokine production and parasympathetic 
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activity restrains sympathetic activity (McEwen, 2006a). The synergistic effects of multiple 
primary mediators and primary effects exerting themselves with secondary outcomes 
progressively strains the organism until a breaking-point. AL becomes overloading when tertiary 
outcomes emerge with the manifestation of clinical endpoints such as cardiovascular disease and 
mortality.  
In an evolutionary biological perspective, allostatic overload (McEwen & Wingfield, 
2003) occurs in two variants. First, type I allostatic overload occurs when energy demands exceed 
energy income, representing a negative energy balance. For example, lack of food because of 
habitat changes results in emergency life sustaining responses that pit the organism into a survival 
mode whereby energy stores are uncompromisingly mobilized from stores as GCs take charge 
(Goymann & Wingfield, 2004; Korte, Koolhaas, Wingfield, & McEwen, 2005). Second, type 2 
allostatic overload occurs if energy demands are not exceeded and the organism continues to take 
in or store as much or even more energy than it needs, representing a positive energy balance. For 
example, today’s industrialized agricultural products allow for massive food supplies that 
contribute to troubling obesity and metabolic problems (McEwen & Wingfield, 2003). 
Transcending theory, AL and allostatic overload have been the subject of a growing empirical 
literature that holds as central tenants the advantages of assessing multiple biomarkers, 
particularly primary mediators (McEwen, 2003b), at sub-clinical levels as a function of different 
contexts (e.g., socio-economic status, stressful life events, toxic workplaces). 
 
Measuring allostatic load  
Work by Teressa Seeman and colleauges has been instrumental in developing an AL index 
that encompasses primary mediators and secondary outcomes to predict tertiary outcomes. The 
traditional count-based AL index was based on analyses from the MacArthur Studies of 
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Successful Aging, a cohort of high-functioning American older adults ages 70 to 79 followed 
longitudinally. The original AL index included 10 biomarkers from neuroendocrine (cortisol, 
adrenalin, noradrenalin, and dehydroepiandrosterone-sulphate (DHEA-S)), metabolic (total 
cholesterol to high density lipoprotein- (HDL) cholesterol, HDL-cholesterol, glycosylated 
hemoglobin (HbA1c), and waist-to-hip-ratio), and cardiovascular  (systolic and diastolic blood 
pressure) systems (Seeman et al., 1997a). Once all biomarker values were obtained from the 
sample, participants’ values falling within the highest-risk with respect to the sample’s biomarker 
distributions. This has traditionally been the 75th percentile for biomarkers whereby high levels 
denote disease vulnerabilities (e.g., glucose, LDL-cholesterol), while the 25th percentile is for 
biomarkers whereby low levels are unhealthy (e.g., DHEA, HDL-cholesterol). The AL index is 
then calculated by adding together the number of  biomarkers that reach these cut-offs. Using this 
multi-systemic index that has subsequently included diverse biomarkers (see Table 1) and 
alternative calculations, numerous studies have assessed the relationship between antecedents of 
AL and the functional significance of high AL.  
 By applying this AL index in analyses of the MacArthur cohort, it was shown that 
increased AL levels are related to cognitive and physical impairments at baseline and associated 
declines over three years, as well as an increased risk of having cardiovascular disease (CVD) 
(Seeman, Singer, Rowq, Horwitz, & McEwen, 1997). At 7-year follow-up, those with the highest 
AL levels were at greatest risk of cognitive and physical decline as well as risk of CVD and even 
all-cause mortality. Note that while differences were found when using neuroendocrine (stress 
hormones and DHEA-S) versus metabolic syndrome biomarkers (glyco-lipids, blood pressure, 
adiposity), the multi-systemic AL index was better than using only single biomarkers or the 
aforementioned clusters to predict outcomes (Seeman, McEwen, Rowe, & Singer, 2001). In a 
similar cross-sectional analysis, it was shown that primary mediators contribute independently of 
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cardiovascular and metabolic risk factors in predicting cognitive and physical functioning declines 
(Karlamangla, Singer, McEwen, Rowe, & Seeman, 2002). Fortunately, even in old age and 
regardless of sex, decrements in AL over 2 and 4 years diminishes one’s risk of dying 
(Karlamangla, Singer, & Seeman, 2006).  
  These results were cross-culturally complemented using the Social Environment and 
Biomarkers Study of Aging with Taiwanese aged 54 to 71. Consistent with the MacArthur cohort, 
increased AL was associated with increased 3-year mortality risk (Goldman et al., 2006b). Seplaki 
and collaborators have contributed several important methodological studies using the Taiwanese 
cohort, showing that increased AL is related to poorer health status (self-rated health, activities of 
daily living, mobility, temporal orientation), depressive symptoms, and cognitive impairments 
(Seplaki, Goldman, Glei, & Weinstein, 2005; Seplaki, Goldman, Weinstein, & Lin, 2004, 2006). 
Furthermore, 3-year mortality risk, mobility limitations, cognitive decline, and depressive 
symptomatology were predicted by higher AL, but driven differentially by traditional clinical risk-
factors vs. neuroendoimmunological mediators (Goldman, Turra, Glei, Lin, & Weinstein, 2006a).  
 Seplaki and Goldman’s analyses are the first to link geriatric depression to AL. About 8-
20% of community-dwelling older adults will experience depression (Brundtland, 2001), which is 
currently the second leading cause of invalidity in the Western world after cardiovascular disease 
(WHO, 2001) and will further effect an estimated 1.2 to 2 billion people over the ages of 60 from 
2025 to 2050 (WHO, 2002). Adverse psychosocial factors throughout life lead to higher AL 
levels, and by implication, to greater risk of psychopathologies as a whole. Indeed, individuals 
with increased perceived stress are more likely to have increased AL levels (Glei, Goldman, 
Chuang, & Weinstein, 2007; Goldman, Glei, Seplaki, Lui, & Weinstein, 2005) and risk of 
developing physical and psychiatric symptoms. It is important to note that such disease 
manifestations are rooted in past stressful experiences such as during working years. 
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 As one of the most noxious stressors adults can experience before retirement and 
transitions into older age, job insecurities and adverse working conditions powerfully effect 
disease trajectories (Taylor, Repetti, & Seeman, 1997) and have been the subject of numerous 
empirical AL studies (Bellingrath, Weigl, & Kudielka, 2009; Fischer et al., 2009; Johansson, 
Huang, & Lindfors, 2007; Juster et al., In Press, In Press; Kinnunen, Kaprio, & Pulkkinen, 2005; 
Langelaan, Bakker, Schaufeli, van Rhenen, & van Doornen, 2007; Li et al., 2007; Schnorpfeil et 
al., 2003; Sun, Wang, Zhang, & Li, 2007; von Thiele, Lindfors, & Lundberg, 2006). Taken 
together, work-related factors (e.g., job demands, limited decision making, effort-reward 
imbalance, burnout symptoms) exert an adverse effect on AL levels. These workplace studies 
have turned the focus onto the psychosocial antecedents of AL at younger ages; however, due to 
their cross-sectional design, can give only limited prospective indications of how the AL index 
might be associated with disease outcomes in later life.  
 Decomposing the biopsychosocial factors that contribute to specific disease trajectories is 
the next step in substantiating the prospective utility of the AL model in detecting problems of the 
mind and body alike. Moreover, AL indices in conjunction to triangulation of methods may 
represent an increasingly accurate means of evaluating an individual’s global health (Picard et al., 
2011). This represents a holistic state emerging from the integration of multiple life domains that 
ultimately determine one’s resilience, longevity, and life satisfaction. One must bear in mind that 
AL levels steadily increase with age (Juster et al., 2010) and because of this, it is increasingly 
important to assess AL at earlier ages, particularly during major developmental stages that shape 
our neurocognitive systems and patterns of responding to life’s stressors (Cicchetti, 2002). Of 
particular interest are the “biological signatures” (Gruenewald, Seeman, Ryff, Karlamangla, & 
Singer, 2006) that might characterize unique psychopathological manifestations. Such biological 
signatures might give indications of an individual’s probability of developing particular ailments 
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in the future. In this vein, we turn now to literature on the development of AL and 
psychopathology as they begin in early life.   
 
Biological Embedding in Early Life 
 Early life adversities can unfavorably alter allostatic mechanisms (McEwen, 2003a). 
Hertzman introduced the term biological embedding to characterize the processes whereby 
cumulative disadvantages and stressful and/or traumatic experiences during youth lead to 
calibrations of the individual’s life-long response patterns to stressors that  predispose them to 
morbidities and premature mortality (Hertzman, 1999; Hertzman & Wiens, 1996). Based on 
groundbreaking studies of maternal handling in rodents (Meaney, Aitken, van Berkel, Bhatnagar, 
& Sapolsky, 1988), exemplary parenting in rhesus monkeys (Suomi, Delizio, & Harlow, 1976), 
and social dominance hierarchies in free-ranging baboons (Sapolsky, 2005), Hertzman further 
argues that biological embedding occurring across the animal kingdom parallels socio-economic 
gradients in humans.  
 
Early adversity and low socio-economic status 
Before birth and thereafter, a child’s development is heavily influenced by factors related 
to socioeconomic status (SES) and linked to detectable AL levels in preadolescence. Gary Evan’s 
pioneering work has demonstrated that as early as age nine, increased AL indices are associated 
with greater frequency of factors more prevalent in low SES environments (e.g., crowding, noise, 
violence, single parenthood) (Evans, 2003). By age 13, early adversities in combination with low 
maternal responsiveness exacerbate AL levels further (Evans, Kim, Ting, Tesher, & Shannis, 
2007). Ultimately, exposure to chronic stress during childhood exacts life-long health 
    Transdisciplinary Allostatic Load Review 
	   16 
consequences and propels youths to view the world as more threatening and challenging 
(McEwen, 2003a).  
At the core of adverse biological embedding in disadvantaged youths is cortisol’s ability to 
modulate cognitive processes that increase vigilance (Buchanan & Lovallo, 2001; Lupien et al., 
2006). Consistently, we reported that low SES school-aged children have increased cortisol levels 
in the absence of attention and memory impairments (Lupien, King, Meaney, & McEwen, 2001). 
Lower SES children also report feeling that things in life are more impossible in an emotional 
plausibility task used in a separate study (Lupien et al., 2005), perhaps explaining how individuals 
born into low SES often remain less educated or wealthy. This intriguing result does not underlie a 
cognitive deficit per se, but nevertheless represents a cognitive divergence that might impact how 
low SES children approach and/or avoid certain life situations and opportunities. By age 17, 
adolescents that have lived in chronic poverty not only have increased AL levels but also working 
memory impairments (Evans & Schamberg, 2009). Another study found that 9th to 12th grade 
adolescents coming from families with lower education (Goodman, McEwen, Huang, Dolan, & 
Adler, 2005) also had higher AL indices, which suggests that SES-related vulnerabilities are 
indeed partly inter-generationally passed on.  
On the other hand, childhood SES does not determine health by itself, as life trajectories in 
social mobility, social relationships, and parental bonding interactively predict AL levels in 
adulthood  (Singer, Friedman, Seeman, Fava, & Ryff, 2005; Singer & Ryff, 1999). While 
resiliency factors like good parenting behavior can help buffer the effects of economic hardships 
(Houston & Vavak, 1991), the absence of facilitation when facing early stressful situations only 
contributes further to earlier signs of AL (Hamil-Luker & O'Rand, 2007; Repetti, Taylor, & 
Seeman, 2002). Low SES, in addition to factors such as dysfunctional familial dynamics and 
abuses, will shape a child’s ability to discriminate threatening from non-threatening information 
    Transdisciplinary Allostatic Load Review 
	   17 
that consequently distinguishes whether cognitive processes will lead to hardiness against or 
heightened sensitivity to stressors (Lupien et al., 2006).  
 
The ‘risky’ family, inter-parental conflict, child abuse, and cognitive adaptations 
The risky family model describes family systems marked by chronic interpersonal 
dysfunction (Repetti et al., 2002). Children growing up in risky families with high conflict and 
aggression as well as cold, unsupportive, and/or neglectful parenting are more likely to experience 
marked impairments in AL biomarker functioning, social competencies, impaired growth, and 
sexual development that can precipitate disease outcomes in adulthood (Repetti et al., 2002; 
Taylor et al., 1997). Even when family dysfunction leads to dissolution, symptoms of high chronic 
stress exposure can be pervasive for offspring. For example, parental divorce can represent a 
major stressful life event for some youths that can lead to geographic relocations (Braver, Ellman, 
& Fabricius, 2003), altered circadian HPA-axis functioning (Kelly, Young, Sweeting, Fischer, & 
West, 2008), increased AL levels (Evans, 2003; Evans et al., 2007), and increased risk of 
depressive symptoms (Chase-Lansdale, Cherlin, & Kiernan, 1995; Gore, Aseltine, & Colton, 
1992; Huurre, Junkkari, & Aro, 2006). Essentially, youths that must attend to constant barrages of 
stressful circumstances in the absence of coping resources are more vulnerable to numerous stress-
related diseases throughout their lifetimes. 
Unfortunately in some cases, risky family climates sometimes transform into direct verbal, 
emotional, physical, and sexual abuse, and/or neglect of youths that can further contribute to 
deregulations in HPA-axis function and increased AL (Cicchetti & Rogosch, 2001; McEwen, 
2000b). Furthermore, children with blunted morning cortisol levels who have been emotionally 
maltreated and/or neglected, but not physically and/or sexually abused make more false 
recognition memory errors (Cicchetti, Rogosch, Howe, & Toth, 2010b), as do adults who were 
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similarly maltreated when young (for a review see Howe, Toth, & Cicchetti, 2006). That specific 
forms early life traumas have differential impacts on HPA-axis functioning represents an 
important development towards the identification of neurobiological signatures linked to 
psychopathological vulnerabilities (Cicchetti, Rogosch, Gunnar, & Toth, 2010a; Heim, Newport, 
Mletzko, Miller, & Nemeroff, 2008; Heim, Plotsky, & Nemeroff, 2004). A review by Bauer and 
Boyce (2004) suggests that child abuse and intra-familial dysfunctions are also associated with 
numerous tertiary outcomes of AL. This literature collectively suggests that early adversities and 
familial dysfunctions contribute to biological embedding that alters how youths perceive and 
cognitively interpret past, present, and future stressors.  
It is important to highlight how physiological dysregulations are conceptually linked to 
eventual cognitive deficits, but developing cognitive capacities in early life can also function as 
perpetuators of vicious circles that amplify the effects of chronic stress in promotion of impending 
psychopathology. Such cognitive processes have been touched upon by the concept of 
preservative cognitive appraisals (Brosschot, Gerin, & Thayer, 2006; Brosschot, Pieper, & 
Thayer, 2005; Brosschot & Thayer, 2003) defined as over-activated cognitive representations of 
stressors (e.g., excessive worrying, rumination, and anticipatory stress) that prolong stress 
responses and promote allostatic states and AL. Just as individual differences in exposure to early 
adversities can modulate cognitive schemas that impel preservative cognitions, so too can the 
reversal of these propensities by psychotherapeutic means and broader social policies. 
As prevention is not always possible and children must often endure face familial 
challenges until the end of adolescence and thereafter, the reversal of AL and psychopathological 
sequelae might be ideally implemented through early interventions (Shonkoff, Boyce, & McEwen, 
2009). Community outreach programs and psychotherapies that aim to provide family education, 
moral, and social support to both parents and youths can lessen the impact of early childhood 
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adversity (Bauer & Boyce, 2004) and effectively reduce, for instance, delinquency rates (Gomby, 
Larner, Stevenson, Lewit, & Behrman, 1995). Notwithstanding, public education is crucial for 
garnering the support and the resources necessary to sustain and refine these programs (Bauer & 
Boyce, 2004). Recognizing that the problem is transdisciplinary in nature is essential and has the 
potential to contribute to the success of these programs (Kessel et al., 2008). It is during these 
formative years that positive factors can counteract the biological embedding impelled by negative 
circumstances. As the following will illustrate, buffering the effects of AL during critical periods 
can facilitate resilience. 
 
Life cycle model of stress 
 The timing and duration at which major stressors and/or traumas are experienced 
profoundly effects the neurological development and the vulnerabilities or resistance individuals 
have towards experiencing specific psychopathologies (Lupien, McEwen, Gunnar, & Heim, 
2009). With regards to brain regions central to HPA-axis regulation in humans, the hippocampus 
attains complete maturation first at age two, the prefrontal cortex (PFC) next between ages eight to 
fourteen, and finally the amygdala continues to grow slowly until the late 20s (Giedd et al., 1996; 
Yakovlev, 1967). The life cycle model of stress proposed by Lupien, McEwen, Gunnar, and Heim 
(2009) states that exposure to adversity and chronic stress during key critical periods can impair 
the development of these brain regions, particularly those that have not fully matured. In this 
manner, smaller regional volumes in conjunction to biological signatures (e.g., hypercortisolism 
vs. hypocortisolism) can be used to predict differential risk-profiles for specific psychopathologies 
(e.g., depression vs. post traumatic stress disorder) in adulthood as well as inform when certain 
traumas might have occurred (Lupien et al., 2009).  
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 The growth and decline of these brain regions depends on the developmental phases at 
which the stressors are experienced, which leads to differential effects on HPA-axis functioning: 
(a) prenatal stress leads to programming effects, (b) postnatal stress leads to differentiation effects, 
(c) stress in adolescence leads to potentiation/incubation effects, and (d) stress in adulthood and 
aging culminate with maintenance/manifestation effects (Figure 4). For example, if an individual 
experiences major stressors in early adulthood, there is less chance that this will structurally affect 
their already fully matured hippocampus or frontal lobes, but could instead lead to hypertrophy of 
the amygdala as this region is still maturing. This may then lead to maintenance/manifestation 
effects and psychopathologies later on in adulthood.  
 This model brings together the hithero opposing neurotoxicity hypothesis (Sapolsky, Krey, 
& McEwen, 1986) and vulnerability hypothesis (Gilbertson et al., 2002):  the former argues that 
prolonged exposure to GCs causes neurological damage, while the latter argues that neurological 
impairments are the cause of abnormal GCs dysregulations, and as such, represent a risk-factor for 
the development of psychopathologies rooted in genetics and early life events (Lupien et al., 
2009).  
 In this vein, early adversities are associated with neurological impairments at the level of 
the hippocampus, amygdala, and PFC that render individuals more vulnerable to developing 
numerous psychopathologies (McEwen & Gianaros, 2010; Teicher et al., 2003). Animal studies 
reveal that both prenatal and postnatal exposures biologically embed the HPA-axis by shaping 
cerebral regions like the hippocampus (Champagne & Meaney, 2001; McEwen, 2003a) that leads 
to programming and differentiation effects. In humans, children who have experienced severe 
abuse show decreased overall brain volumes and are more susceptible to earlier onsets of post-
traumatic stress disorder (PTSD) with longer disease durations (De Bellis et al., 1999).  
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 In contrast to adult studies that consistently report smaller hippocampal volume (HV) in 
PTSD patients (Bremner et al., 1997; Karl et al., 2006), most child PTSD studies find no evidence 
for structural hippocampal aberrations (Carrion et al., 2001; De Bellis, Hall, Boring, Frustaci, & 
Moritz, 2001; De Bellis et al., 1999). A recent meta-analysis confirmed that children with PTSD 
do not necessarily experience smaller HV, although adults with histories of childhood 
maltreatment often do (Woon & Hedges, 2008). For instance, individuals with a history of 
childhood sexual abuse have decreased HVs (Vythilingam et al., 2002) as well as 
neuropsychological deficits (Bremner, Vermetten, Afzal, & Vythilingam, 2004; Navalta, Polcari, 
Webster, Boghossian, & Teicher, 2006). A recent study uncovered a sex disparity in relation to 
these early exposures, whereby low birth weight predicted smaller HV in adulthood only in 
women reporting low parental care but not men (Buss et al., 2007). These findings suggest that the 
effects of the prenatal environment combined with childhood maltreatment may not appear until 
adulthood or late adolescence; however, it is possible that these children had smaller HV to begin 
with due to prenatal factors.  
 One’s risk of developing major depression is also modulated by early adversity. 
Individuals with major depression often have heightened basal cortisol levels (Burke, Davis, Otte, 
& Mohr, 2005; Porter & Gallagher, 2006), hippocampal-dependent declarative memory 
impairments (Burt, Zembar, & Niederehe, 1995; Fossati et al., 2004) and encoding deficits 
(Bremner, Vythilingam, Vermetten, Vaccarino, & Charney, 2004). Additionally, they have 
decreased HV (Campbell, Marriott, Nahmias, & MacQueen, 2004; Videbech & Ravnkilde, 2004) 
that actually predicts the frequency and duration of subsequent major depressive episodes 
(Campbell et al., 2004; MacQueen et al., 2003; Sheline, Sanghavi, Mintun, & Gado, 1999; 
Videbech & Ravnkilde, 2004). When investigating the association between major depression and 
reduced HV, it is important to take into account whether participants have a history of abuse or 
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maltreatment during childhood (Heim & Nemeroff, 2001). For example, women with a history of 
childhood sexual or physical abuse are more likely to have hyperactive HPA-axis functioning 
(Heim et al., 2000) as well as smaller HV, whereas women without a history of abuse often show 
similar HV to healthy controls (Vythilingam et al., 2002). That differences in history of abuse lead 
to variant neuroendocrine functioning suggest that the nature and especially the timing of stressors 
and/or traumas lead to alternative forms of biological embedding with predispositions to specific 
diseases (Cicchetti et al., 2010a). 
Consistent with this idea, patients with PTSD often show decreased levels of basal cortisol 
(Yehuda, Golier, & Kaufman, 2005) instead of the hypercortisolemic profile often found in 
depression. These alterations in HPA-axis functioning may commence in childhood following 
abuse or neglect, subsequently increasing the risk for PTSD in adulthood. Indeed, combat veterans 
with PTSD are more likely to have histories of childhood abuse in comparison to veterans who do 
not develop PTSD (Bremner, Southwick, Johnson, Yehuda, & Charney, 1993). While adult PTSD 
patients have decreased HV (Karl et al., 2006; Smith, 2005), hippocampal atrophy may be either a 
consequence of PTSD, or instead a form of vulnerability towards developing PTSD (Gilbertson et 
al., 2002; Lupien et al., 2007). Supporting this is a classic monozygotic-twin study, whereby 
combat veterans who went to war and developed PTSD as well as their twins who did not go to 
combat both had smaller HV in comparison to twin-pairs that did not develop PTSD (Gilbertson et 
al., 2002). By contrast, when HV was measured soon after exposure to trauma and before the 
development of PTSD symptoms, no differences were found between those that later developed 
PTSD and those that did not (Bonne et al., 2001). This chicken-egg phenomenon will only be 
better understood with prospective life-spanning studies. 
Dysregulations of HPA-axis activity in psychiatric conditions such as depression and 
PTSD may alter other physiological biomarkers and consequently increase AL (McEwen & 
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Gianaros, 2010). In the only study of its kind in the AL literature, it was found that mothers of 
childhood cancer survivors who experienced increased distress and PTSD symptoms also had 
increased AL levels driven in part by lower cortisol levels (Glover, Stuber, & Poland, 2006) in 
addition to smaller right HVs (Glover, Garcia-Arcena, & Mohlman, 2008) when compared to 
control mothers. These analyses utilized both high and low ends of cortisol variation since 
hypocortisolism characterizes certain diseases (Fries, Hellhammer, & Hellhammer, 2005). Indeed, 
hypocortisolism has been empirically substantiated vis-à-vis AL and symptoms of chronic fatigue 
syndrome (Goertzel et al., 2006; Hellhammer, Schlotz, Stone, Pirke, & Hellhammer, 2004; 
Maloney, Boneva, Nater, & Reeves, 2009; Maloney et al., 2006; Smith, Maloney, Falkenberg, 
Dimulescu, & Rajeevan, 2009), post-traumatic stress disorder (Glover, 2006; Glover et al., 2008, 
Glover et al. 2006), and burnout (Juster et al., 2010). More research is needed to disentangle 
specific pathways emergent from earlier life experiences that shape the neurobiological substrates 
associated with these differential biological signatures (e.g., hypo- versus hyper-cortisolism). In 
addition to furthering our understanding of causal mechanisms, such knowledge would guide 
diagnostic approaches and improve the efficacy of early interventions. 
 
Conclusion and future directions 
Early adversities such as low SES (for a review, see (Dowd, Simanek, & Aiello, 2009), 
living in risky family environments, suffering neglect and/or abuses, can all lead to biological 
embedding that increases AL and lifelong psychopathological susceptibilities. We believe that 
these deleterious effects on the hippocampus, amygdala, PFC, and overall brain functioning 
depend on the developmental timing and duration of elevated GC exposure (Lupien et al., 2009). 
The balance between adaptive neuroplasticity and neurodegeneration suggests an important 
dynamic, whereby marked brain changes occur even after maturation and persist throughout the 
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life cycle. Therefore, dynamic parameters of brain changes in childhood and adolescent 
neurodevelopment, as well as later life alterations should be taken into account when analyzing 
processes mediating the consequences of stress exposure on the brain. An important additional 
element of this puzzle that has received limited substantiation in the AL literature are the genetic 
vulnerabilities we inherit. Indeed, genetic and epigenetic interactions can function as strings of 
fate that can protract biological embedding effects throughout a lifetime. Yet, genetic 
vulnerabilities and early adversity can also be reversed in certain enriching contexts, underlining a 
probabilistic rather than deterministic perspective. 
For decades, diathesis-stress models have dominated theoretical discourse on how genetic 
predispositions to diseases can be amplified when stressors reach an intolerable threshold. This 
concept has many merits; however, it limits science’s ability to go beyond hypotheses that fixate 
on vulnerability and which often cannot account for how diatheses sometimes reverse into a 
resilient trait. In this spirit, the Swedes have an expression called maskrosbarn (dandelion child) 
and a neoglism called orkidebarn (orchid child) that offers an empowering, alternative perspective 
to append into diathesis-stress models (Boyce & Ellis, 2005). Quoting David Dobbs; “most of us 
have genes that make us as hardy as dandelions: able to take root and survive almost anywhere. A 
few of us, however, are more like the orchid: fragile and fickle, but capable of blooming 
spectacularly if given greenhouse care” (Dobbs, 2009, p. 60). 
This perspective states that inherited genotypes with potentially negative consequences can 
be modulated to generate a multitude of potentially positive phenotypes. In terms of evolution, 
natural selection has permitted certain “bad” genes to remain in the gene pool if, under certain 
circumstances, they could enhance fitness and survival (Dobbs, 2009). With this in mind, it is 
important to recognize that diverse interactions among nature (genes) and nurture (environment) 
are unremittingly co-dependent.  
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Human Genetics: A Common Missing Piece of the Model 
A comprehensive review on the antecedents of AL must incorporate genetic underpinnings 
involved in diathesis-stress models. Genetics provide insights into the interaction between stress 
exposure and the regulation of internal biological processes across an individual’s lifespan and 
across generations. A rich literature on the genetics involved in stress-related diseases is now 
reviewed to encourage future investigations. 
 
Twin studies 
Twin studies have demonstrated significant genetic contribution to basal cortisol secretion 
(Linkowski et al., 1993; Steptoe, van Jaarsveld, Semmler, Plomin, & Wardle, 2009), stress-
reactivity (Steptoe et al., 2009), and other biomarkers commonly employed in the AL model (De 
Geus, Kupper, Boomsma, & Snieder, 2007; Williams, Blanche, & Krauss, 2005). In a study 
assessing salivary cortisol in unaffected twins discordant for affective disorders (Vinberg, 
Bennike, Kyvik, Andersen, & Kessing, 2008), it was found that high-risk twins displayed elevated 
evening cortisol levels compared to low-risk twins. Notably, the high-risk twins in this study 
previously reported signs of discrete cognitive dysfunction (Christensen, Kyvik, & Kessing, 2006) 
and a tendency for higher levels of neuroticism (Vinberg, Mortensen, Kyvik, & Kessing, 2007). 
Overall, twin studies suggest that genetic factors control the expression of HPA-axis activity.  
Although findings are mixed (Kirschbaum, Wust, Faig, & Hellhammer, 1992), quantitative 
genetic modeling has shown significant heritability for cortisol reactivity to a stressor (Steptoe et 
al., 2009). In a recent meta-analysis that evaluated all published twin studies that assessed heart 
rate or blood pressure reactivity to stress exposure, the pooled heritability estimates ranged from 
26% to 43% for reactivity to psychosocial stress (i.e., mental stressor) and 21% to 55% for 
reactivity to physiological stress (i.e., cold pressor test) (Wu, Snieder, & de Geus, 2009). These 
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studies highlight the importance of genetics as an underlying mechanism in individual differences 
in stress reactivity. 
 In uncovering the molecular pathway between genetic variability and AL, twin studies 
have examined the genetic underpinnings of additional biological variables found within the AL 
model. In a study of Swedish elderly twins, a dominant genetic component was reported for low-
density lipoprotein, glucose, HbA1C, and C-reactive protein (Rahman et al., 2009). In a study 
assessing genetic and environmental contributions to cardiovascular disease and metabolic 
syndrome (Elder et al., 2009), it was reported that cholesterol and triglycerides were highly 
heritable (56% to 77%), and waist circumference, glucose, insulin, insulin resistance, and blood 
pressure were moderately heritable (43% to 57%). Common environmental factors contributed to 
23% to 40% of the variables of waist circumference, SBP, and glucose, suggesting a dominant 
genetic influence on total variance of factors associated with disease. While twin studies provide 
important information, the magnitude of heritability reveals little about the genetic structure of 
particular endophenotypes and plausible number of genes involved.   
 
Genetic association studies in humans  
Association studies have provided essential information on how specific genes contribute 
to the regulation of key biological processes involved in how sensitive individuals are likely to 
respond to stressors. Reports of gene-environment interactions demonstrate just how variation in 
genetic profiles interact with environmental stimuli, resulting in differential health outcomes or 
multifinality (Cichetti & Toth, 2009). In accordance with the stress-diathesis model, individual 
differences at the genetic level may alter primary effects and secondary outcomes, resulting in 
varied susceptibilities to tertiary outcomes. Over the years, a number of genetic polymorphisms 
have been assessed in association with stress and stress-related disease in humans, including the 
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serotonin transporter polymorphism (5-HTTLPR: short/long) (Caspi et al., 2003), brain derived 
neurotrophic factor (BDNF: Met66Val)(Vinberg et al., 2009), apolipoprotein E (APOE: epsilon 
e4) (Fiocco, Poirier, Joober, Nair, & Lupien, 2008), and the catechol-O-methyltransferase gene 
(COMT: Met158Val)(Yavich, Forsberg, Karayiorgou, Gogos, & Mannisto, 2007).  
The 5-HTTLPR gene has been widely investigated for its role in affective disorders. 
Studies show that individuals with the short allele display greater stress-reactivity to psychosocial 
stress, with the greatest response in those homozygotic for the short allele (Gotlib, Joormann, 
Minor, & Hallmayer, 2008; Way & Taylor, 2010). Further, it is reported that the short allele 
interacts with stressful life events to increase risk of depression (Caspi et al., 2003; Kendler, 
Kuhn, Vittum, Prescott, & Riley, 2005) and neuronal activation of brain regions involved in 
depression (Canli et al., 2006). The 5-HTTLPR has also been shown to moderate the association 
between lipid profiles and depression prevalence in older adults, with the association apparent 
only in homozygotic carriers of the short allele (Kim et al., 2009). On the other hand, a recent 
meta-analysis failed to conclude that the 5-HTTLPR genotype alone or in interaction with 
stressful life events is associated with an elevated risk of depression regardless of sex (Risch et al., 
2009). Genetic polymorphisms may thus affect the magnitude of AL acquired over time as an 
individual faces and responds to environmental challenges, which then determines risk of adverse 
psychological and health sequelae associated with biological concomitants of the AL model. 
COMT catalyzes the degradation of catecholamines like dopamine in the brain (Yavich et 
al., 2007) and is, as will be elaborated in a separate section, linked to psychotic disorders 
(Craddock, Owen, & O'Donovan, 2006). The gene that codes for COMT contains a functional 
common Val158Met polymorphism, with the Val allele exhibiting a three- to four-fold increase in 
enzyme activity compared to the Met allele (Chen et al., 2004). Recent studies show that, 
compared to Val/Val carriers, healthy adults with the Met/Met genotype display a diminished 
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opiod system response and greater sensory and affective ratings of pain following a sustained pain 
challenge (Zubieta et al., 2003) and increased limbic and prefrontal activation following the 
presentation of unpleasant stimuli (Smolka et al., 2005). These studies suggest that the Met allele 
lowers physiological and psychological resilience against negative environmental challenges, 
which may increase the risk of stress-induced disease. 
In a study that assessed reactivity to a psychosocial stressor in healthy controls in risk 
probands and major depressive disorder patients, an association between COMT genotype and 
stress reactivity was reported (Jabbi et al., 2007). This association differed depending on group 
status: Met/Met carriers displayed greater cortisol and adrenalin reactivity following the stressor. 
Yet, in at risk probands, the Val/Val genotype group displayed greater reactivity. No association 
was found in the patient group; however, this was attributed to current medication use. This study 
presents the possibility that epigenetic mechanisms are at play: risk exposure alters the function of 
the gene, which then biases an individual’s response to subsequent stressors.  
 
Epigenetics  
Epigenetics examines changes in DNA methylation and histone modifications produced by 
perturbations in the environment (e.g., early adversity) that in turn alter the function, but not the 
structure, of a gene. Research shows that changes incurred through epigenetics are stable and can 
even be transmitted inter-generationally (Meaney & Szyf, 2005). While a majority of epigenetic 
findings stem from animal research (Francis, Diorio, Liu, & Meaney, 1999; Szyf, Weaver, 
Champagne, Diorio, & Meaney, 2005; Weaver et al., 2004), two studies have thus far evaluated 
the epigenetic model in humans.  
A twin study that examined the genetic and environmental contributions to cortisol 
reactivity in a cohort of 19-month-old twins from high and low family adversity found that high 
    Transdisciplinary Allostatic Load Review 
	   29 
family adversity has a differentiation developmental effect on cortisol reactivity (Ouellet-Morin et 
al., 2008). Specifically, both genetic and environmental factors explained the variance in cortisol 
reactivity to a mild stressor (i.e., unfamiliar situation) for twins from low family adversity. By 
contrast, variance in cortisol reactivity was only explained by shared and unique environmental 
factors in twins who had experienced high family adversity (characterized as having four of the 
following; maternal smoking during pregnancy, low birth weight, low family income, low 
maternal education level, single parenthood, young motherhood, and maternal hostile or reactive 
behaviors). As discussed earlier, infants exposed to adverse environments likely undergo 
alterations in their biological embedding over and above any genetic contributions, and yet the 
pathways driving stress responsivity can differ markedly from one family context to the other. 
Until more research is conducted, the precise manner whereby such mechanisms promote 
resilience or vulnerability is speculative, but might involve differential neurodevelopmental 
processes.  
Epigenetic differentiation precipitated by early adversity might effect GC gene promotor 
expression in the hippocampus via DNA methylation. A recent postmortem study (McGowan et 
al., 2009) assessing the epigenetic regulation of the GC receptor in suicide victims with or without 
a history of childhood abuse reported differential neuron-specific GC receptor promotor in 
postmortem hippocampi. Specifically, decreased levels of GC receptor mRNA and increased 
cytosine methylation of the GC receptor promotor was found in abused suicide victims.  Early 
adversity can also induce modifications in the methylation status of the BDNF gene, which can be 
transmitted from one generation to the next (Roth, Lubin, Sodhi, & Kleinman, 2009). While these 
studies are tips of the iceberg, they nonetheless suggest that genetic effects and epigenetic 
interactions might influence AL susceptibilities via physiological recalibrations of the HPA-axis 
and regulatory neural substrates.  
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Genetic study of allostatic load 
To date, only one study has directly assessed the association between genetic variance and 
AL (Smith et al., 2009). In a population-based study of chronic fatigue syndrome, 182 Caucasian 
participants were genotyped and an AL index was calculated, based on measures representing 
metabolic, cardiovascular, inflammatory, HPA-axis and autonomic activities. Polymorphisms in 
32 candidate genes related to HPA-axis activity, neurotransmitter systems, inflammation, 
cardiovascular, and metabolic functions were analyzed. After correcting for covariates and 
multiple comparisons, genetic polymorphism of the gene that codes for angiotensin-I converting 
enzyme (ACE C/T: rs4968591) remained significantly associated with AL status. Specifically, 
participants with the T allele of the ACE gene were more likely to display a higher AL index than 
participants with the C allele.  
ACE catalyses the conversion of angiotensin-I (Ang-I) to Ang-II, which is both pro-
inflammatory and pro-oxidant and thus plays an important role in cardiovascular, endocrine, and 
immune functions (Garg & Yusuf, 1995; Malik et al., 1998; Maschio et al., 1996). The ACE 
enzyme further converts Aß42 to Aß40 in the brain (Zou et al., 2009), which is implicated in the 
development of neuronal plaques of particular concern in older life dementias. Indeed, 
polymorphism of the ACE gene has been associated with type-II diabetes mellitus (Stephens et al., 
2005), obstructive pulmonary disease (Tkacova et al., 2005), and Alzheimer’s disease (Kolsch et 
al., 2005). As the common ACE polymorphism in these studies (ACE I/D) is not in linkage 
disequilibrium with the ACE T/C gene, additional prospective research is needed to confirm the 
association between ACE and AL and any functional, long-term consequences.  
 
Conclusion & future directions 
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Future studies should go beyond the basic stress-diathesis structure and consider genetic 
and epigenetic influences on biological systems that are integral to the AL model. Future 
investigations of genetic mechanisms contributing to AL such as telomere length as tertiary 
outcomes would be immensely informative (Epel, 2009; Epel et al., 2004; Sapolsky, 2004). In 
addition, studies incorporating multiple dimensions of outcomes (biological, psychological, social, 
behavioral, spiritual) and global self-perceptions of health (Jylha, 2009) would help us determine 
how genetic and epigenetic factors interact with other systems and with individual’s health in 
general to promote vulnerability or resilience. Indeed, a more comprehensive understanding of the 
(epi)genetic regulatory mechanisms and their relationship with chronic stress should help inform 
individualized prevention strategies for reducing or minimizing the underpinnings of AL.  
Like the case of the orchid child discussed previously, it is imperative to understand how 
protective factors can be harnessed to dampen the effects of risk factors like harmful genetic 
makeups and/or early adversities. For instance, an exemplary review of gene-stress-behavior 
interactions in adolescent alcohol use outlines how to intervene early to minimize the likelihood 
that inherited vulnerabilities towards alcoholism and associated psychopathologies before 
morbidities manifest themselves (Zimmermann, Blomeyer, Laucht, & Mann, 2007). The interface 
between individuals and foreign substances that endanger health (e.g., cigarettes) is an important 
avenue to pursue with respect to stress research. And yet, these have had little place in the AL 
literature other than as behavioral covariates in statistical equations. As numerous noxious factors 
knowingly and unknowingly enter our bodies to exert deleterious effects, we would do well to 
determine the precise mechanisms of their actions on the brain and body. To address this lacuna, 
we now turn to how environmental toxins can directly or indirectly affect AL throughout life.   
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Environmental Toxins: Mediators or Moderators of Allostatic Load? 
Genetic variance exists in an individual’s ability to absorb, distribute, metabolize, and 
excrete environmental toxins. For example, genotypes associated with heavy metal absorption and 
toxicity include hemochromatosis (Wright et al., 2004), vitamin D receptor (Chuang et al., 2004), 
and apolipoprotein-E (Godfrey, Wojcik, & Krone, 2003). Environmental toxins (ETs) are 
principally industrial chemicals like lead (Pb), methylmercury (MeHg), and polychlorinated 
biphenyls (PCB) that can contribute to functional disruptions, neurodevelopmental delays, 
behavioral as well as cognitive impairments throughout the lifespan (Bradley & Corwyn, 2002; 
Furumoto-Dawson, Gehlert, Sohmer, Olopade, & Sacks, 2007). Unfortunately, ETs have received 
little attention in the AL model, and yet they have the propensity to potently effect AL biomarkers 
by means of mediation or moderation effects at differential periods throughout lifespan 
development (see Table 2).  
 
Vulnerable populations to environmental toxins exposure 
While everyone is vulnerable to ETs, children and older adults are particularly sensitive to 
exposure. Extensive studies of Pb, MeHg, and PCBs reveal multiple mechanisms by which these 
compounds disrupt normal brain development (Landrigan, 1999; Stein, Schettler, Wallinga, & 
Valenti, 2002). Children also have greater exposure to ETs than adults in terms proportioned body 
weight by way of water consumption, food, and air, as well as through increased hand-to-mouth 
and playground behaviors.  
Aging individuals are also highly vulnerable to a lifetime’s worth of accumulated ETs that 
can exacerbate senescence. For instance, toxicokinetic studies have demonstrated that 95% of Pb 
is stored in the skeleton only to then be released into circulation during age-related bone 
demineralization (Rabinowitz, 1991). Data from the National Health and Nutrition Examination 
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Survey (NHANES) confirm that adults over the age of 50 have the highest blood Pb levels (Pirkle 
et al., 1998). Moreover, our elders have much higher exposure to ETs than younger generations 
benefitting from recent bans and/or restrictions. In sum, older adults and youths are extremely 
vulnerable to ETs that can, like chronic stress, increase sensitivities towards disrupted 
development and accelerated brain declines (Lupien et al., 2009).  
 
Environmental toxins as endocrine disruptors 
One plausible pathway whereby ETs impact the body and the brain is through interactions 
with the endocrine system. Early observations of reproductive organ malformations and aberrant 
sexual behaviours in wildlife first unveiled the ability of ETs to interfere with steroid hormones. 
This led to their infamous classification as endocrine disrupting chemicals (Hotchkiss et al., 2008; 
Zala & Penn, 2004), which the World Health Organization defines as “an exogenous substance or 
mixture that alters function(s) of the endocrine system and consequently causes adverse health 
effects in an intact organism, or its progeny, or (sub)populations” (WHO, 2002). Identified 
environmental estrogens and anti-estrogens include certain heavy metals (Pb, cadmium, MeHg), 
industrial chemicals (PCBs, dioxins and furans), pesticides (DDT, Organophosphates), herbicides 
(Atrazine), and plasticizers (Bisphenol A, surfactant) (Darbre, 2006; Weiss, 2007) that are 
dangerous even at very low doses (Denham et al., 2005; Jacobson & Jacobson, 1996).  
As ETs are ubiquitous, affect particularly children and elders, and interact with endocrine 
functioning, they should be addressed by the AL model. In the following paragraph, we will 
examine whether environmental toxins might (1) directly impact the HPA-axis; (2) potentiate 
other chronic stressors; and/or (3) effect individual AL biomarkers. 
 
Environmental toxins and allostatic load 
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While scarcely studied in humans, ETs are believed to function as GC receptor antagonists 
(Johansson, Nilsson, & Lund, 1998) and can alter GC biosynthesis in adrenocortical cells (Li & 
Wang, 2005). Animal studies reveal that dysregulated HPA-axis responses to acute stressors are 
related to heavy metal exposure (cadmium, lead, mercury) and organic environmental 
contaminants (PCBs, solvents, pesticides) in fish (Brodeur, Sherwood, Rasmussen, & Hontela, 
1997; Hontela, Dumont, Duclos, & Fortin, 1995), amphibians (Gendron, Bishop, Fortin, & 
Hontela, 1997), birds (Love et al., 2003), rodents (Meserve, Murray, & Landis, 1992; Vyskocil, 
Fiala, Ettlerova, & Tenjnorova, 1990), and large mammals (Oskam et al., 2004; Zimmer et al., 
2009). In humans, even low levels of Pb exposure correspond to increased cardiovascular (Gump 
et al., 2005) and cortisol reactivity to the cold pressor task in 9-10 year-old children (Gump et al., 
2008). As the cold pressor task is primarily a physical stressor, it will be important to replicate 
these findings using psychosocial stressors that elicit social-evaluative threats known to induce 
greater HPA-axis activations than other laboratory tasks (Dickerson & Kemeny, 2004).   
ETs may directly impair the HPA-axis or alternatively act as mediators of chronic stressors 
like poverty. Indeed, ET exposures are demographically constrained, occurring most frequently in 
socio-economically disadvantaged environments (Sexton, 1997). For instance, children living in 
older houses containing Pb paint (Pirkle et al., 1998) and/or living in the center of large cities are 
exposed to greater Pb levels than those living more peripherally (Brody et al., 1994; Pirkle et al., 
1994; Sexton et al., 2006). Impoverished individuals are also more likely than affluent ones to live 
near environmental hazards like industrial plants, reside in urban areas where ambient levels of 
many air pollutants tend to be higher, eat significantly greater amounts of contaminated fish, and 
be employed in potentially dangerous occupations (Sexton et al., 2000).  
In addition, high Pb levels could be a mechanism whereby family income effects HPA-axis 
functioning in children (Gump et al., 2009). Using data from the Oswego study, increased early 
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childhood blood Pb levels significantly mediated the association between decreased family 
income and augmented salivary cortisol levels following acute stress. While this might denote a 
meditational effect, the direction of the association is indiscernible, as reverse causality remains a 
possibility: adrenocortical reactivity may have effects on the toxicokinetics of blood to bone 
transfers of Pb (Mushak, 2003).  
ETs might also indirectly synergize HPA-axis dysregulations and increase vulnerabilities 
towards inter-generational transmission of psychopathologies. A notable American population 
study recently found that background levels of Pb were associated with increased odds of 
developing major depression in 20-40 year old adults (Bouchard et al., 2009). Interestingly, this 
age range corresponds to the average reproductive years of humans. Our group has previously 
shown that children with increased cortisol levels are more likely to have depressed mothers and 
come from disadvantaged neighborhoods (Lupien, King, Meaney, & McEwen, 2000). It follows 
that living in lower socio-economic strata with increased Pb exposure could directly impact 
children’s HPA functioning or indirectly via the mother’s mental health, or perhaps a mix of both. 
At a transdisciplinary level, such complex interactions among environmental, biological, and 
psychosocial factors in developing children could result in an altered state of global health that 
could lead to psychopathologies and concomitant co-morbidities. The interactions of ETs with 
other types of factors (e.g., early adversity, genetic endowment) may thus lead to complex 
dysregulations at multiple levels that consequently render the individual more susceptible to the 
effects of chronic stress by enhancing the toll of AL.   
In mechanistically considering ETs in interaction with AL, only one group have 
systematically assessed the combined effects of ETs and stressors using the rodent model (Cory-
Slechta et al., 2008). Based on the premise that Pb exposure acts on the mesocorticolimbic 
dopamine pathway (Zuch, O'Mara, & Cory-Slechta, 1998) in semblance to products of the HPA-
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axis, Cory-Schleta and colleagues (2008) confirmed that Pb and GCs interact in this tract. By 
assigning dams to four experimental groups as a function of Pb exposure (waterborne 2 months 
before breeding and into lactation vs. not) and maternal stress (restraint at gestational day 16 and 
17 vs. not), they observed behaviors dependent on this pathway (e.g., locomotion, impulsivity) in 
60-day old offspring. Results showed that the dams exposed to combined Pb and restraint had 
female offspring with higher corticosterone levels than contrast groups (Cory-Slechta, Virgolini, 
Thiruchelvam, Weston, & Bauter, 2004). In a subsequent study that limited the timing of Pb 
exposure to post-weaning periods, it was shown that interactions among Pb and stressors are not 
restricted to maternally mediated exposure (Virgolini, Chen, Weston, Bauter, & Cory-Slechta, 
2005). Even at low levels (10 ug/dL), Pb exposure interacts with prenatal stress to further modify 
both behavioral and corticosterone responses to stressors (Virgolini, Rossi-George, Weston, & 
Cory-Slechta, 2008). These findings translate into a major danger for population health. In the 
United States, the acceptable childhood blood Pb threshold is currently 10 ug/dL. Yet amidst 
public health efforts to restrict exposure, 1.6% of American children ages 1 to 5 have levels 
greater than or equal to 10 ug/dL (Centers for Disease & Prevention, 2005; Jones et al., 2009).  
As far as we know, only one epidemiological study has reported interactive effects of 
stress and Pb in the general population (Peters et al., 2007). In the Normative Aging Study, 
individuals with increased psychological stress, in addition to cumulative Pb exposure, had an 
increased risk of developing hypertension independent of standard covariates. Specifically, those 
reporting high stress levels had 2.65 times greater chance of developing hypertension per standard 
deviation increase in Pb. These results strongly suggest that the effect of Pb on hypertension 
interacts with chronic stress levels independent of demographic and behavioral risk factors. Apart 
from Pb, ETs may exert their influence on the HPA-axis through various pathways: (1) directly by 
affecting the HPA-axis (2) indirectly by mediating the effects of environmental factors on the 
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HPA-axis functioning, and (3) indirectly by potentiating the effects of maternal stress on offspring 
HPA-axis functioning and behavioral outcomes. These pathways may represent an additional form 
of AL that can increase the probability of developing physical and mental disease. While ETs have 
been proposed as mediators or moderators of AL (Loucks, Juster, & Pruessner, 2008), no 
corresponding studies exist and so we must therefore turn to studies of individual AL biomarkers.  
Environmental toxins as disrupters of individual allostatic load biomarkers 
In addition to neuroendocrine effects, ETs can impair cardiovascular, immune, and 
metabolic functions. A positive correlation between Pb exposure and blood pressure has been 
identified in numerous studies (Fewtrell, Pruss-Ustun, Landrigan, & yuso-Mateos, 2004; Gump et 
al., 2005; Nash et al., 2003; Navas-Acien, Guallar, Silbergeld, & Rothenberg, 2007). Increased 
vulnerabilities for cardiovascular morbidities and mortality have even been shown at lead levels < 
5 μg/dL in large epidemiological studies (Menke, Muntner, Batuman, Silbergeld, & Guallar, 2006; 
Muntner, Menke, DeSalvo, Rabito, & Batuman, 2005). Concerning MeHg toxicity, most studies 
have been conducted in populations dependant on fish as a primary food source, such as in the 
Seychelles study (Davidson et al., 1998; Myers et al., 1997) or the Faroe Island study (Debes, 
Budtz-Jorgensen, Weihe, White, & Grandjean, 2006; Grandjean et al., 1992).  
While controversial (Chan & Egeland, 2004; Stern, 2005), several reports substantiate an 
adverse association between MeHg exposure and relative risk of myocardial infarction (Salonen et 
al., 1995) and hypertension (Fillion et al., 2006). Likewise, PCB 126 (a dioxin-like compound) 
exposure in female rats increases cardiovascular risk factors like hypercholesterolemia and 
hypertension (Lind, Orberg, Edlund, Sjoblom, & Lind, 2004). One human study even showed that 
Native Americans with increased PCB levels had an increased risk of developing cardiovascular 
disease through increased synthesis of cholesterol and triglycerides (Goncharov et al., 2008).  
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Although the immunotoxic mechanism of ETs is not well understood, deleterious effects 
have been observed in animals (Esser & Welzel, 1993) and humans (Baccarelli et al., 2002; 
Heilmann, Grandjean, Weihe, Nielsen, & Budtz-Jorgensen, 2006). An accumulating body of 
evidence suggests that in-utero ET exposure might increase susceptibility to infections in young 
children (Dallaire et al., 2006; Weisglas-Kuperus, Vreugdenhil, & Mulder, 2004). In the 
NHANES, exposure to monohydroxy polycyclic aromatic hydrocarbons (derived from incomplete 
combustion of organic matter and fossil fuels including diesel engines, domestic heating, and 
pyrolysis of coal or tobacco smoke) was associated with increased C-reactive protein (Everett et 
al., 2010). In the previous phase of the NHANES study, exposure to cadmium, which is used as a 
pigment and plastic stabilizer, was also positively associated with increased plasma C-reactive 
protein and fibrinogen levels (Lin, Rathod, Ho, & Caffrey, 2009), while Pb exposure was 
associated to inflammatory biomarkers (Songdej, Winters, McCabe, & van Wijngaarden, 2010). 
As mentioned before, ETs also increase lipid profiles (Goncharov et al., 2008). 
Specifically, PCBs and other dioxin-like components are associated with increased risk factors 
representative of metabolic syndrome in Americans (Lee, Lee, Porta, Steffes, & Jacobs, 2007b) 
and Japanese (Uemura et al., 2009) alike. Notwithstanding, differential ET exposures are based 
largely on socio-economic as well as cultural differences both within and between populations that 
should be considered by future investigations.  
 
Conclusion and future directions 
Because several AL biomarkers are effected by or interact with ETs, we believe that they 
should be explored as mediators and/or moderators in the AL model. In particular, elucidating 
how ETs effect developmental trajectories towards pathological outcomes from childhood until 
old age will be important to consider. We have limited this review to the best-characterized ETs 
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(Pb, MeHg, and PCBs), but many other chemicals currently used in numerous commercial goods 
are identified or suspected endocrine disrupters with neurotoxic effects.  Furthermore, the majority 
of ETs reviewed are endocrine disrupting chemicals that alter HPA axis and sex hormone 
functions in humans (Agusa et al., 2007).  
ETs are likely also effected by numerous other factors (psychosocial, biological, 
behavioral). Studying the impact of ETs on psychopathology could be improved by adopting a 
transdisciplinary approach that focuses on the interaction of ETs with multiple levels of outcomes 
existing in parallel. For instance, are the sexes exposed differently to ETs based on gender-typed 
work environments (e.g., factories, primary industries), and how can ETs interact with sex 
hormones to disrupt physiology? We are far from being able to accurately respond to such 
questions. Just in terms of sex differences in ET exposures, genetic interactions, and early 
adversities, much remains unknown, as the concept of “sex” is complex but powerful in 
determining patterns of health and disease. In order to facilitate answers for future inquiries in ETs 
research and all the aforementioned litarature, we next explore nuances among one’s biological 
sex, one’s socio-culturally generated gender identity and behaviors, and the modulating effects of 
sex hormones on AL levels.  
 
Sex, Gender, and Sex Hormones  
One’s sex confers a unique set of vulnerabilities to specific disease pathways. Women are 
more prone to affective and autoimmune disorders, whereas men are more at risk of early 
mortality, substance abuse, conduct/antisocial disorder, and infectious diseases. While men are 
more stress responsive to acute stressors (Kajantie & Phillips, 2006; Kirschbaum, Wüst, 
Hellhammer, 1992; Kudielka & Kirschbaum, 2005), women experience greater subjective distress, 
perhaps due to socio-cultural factors. As this section will elucidate, biological sex, gender-roles, 
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and sex hormones are elusively linked to AL levels. 
The term sex refers to the biological differences between men and women such as genetic 
sex (female XX and male XY chromosomes) and hormonal milieu. For instance, men have higher 
testosterone levels and women have higher estrogen and progesterone levels. These sex steroids 
have both organizational and activational effects that shape sex differences ranging from 
morphology to behavior. Organizational effects refer to permanent actions during a critical early 
developmental period that modulate brain responses to certain stimuli later in life. On the other 
hand, activational effects refer to transient physiological and/or behavioural responses triggered by 
the activation of the matured gonadal axis occuring at any age thereafter.  
Lifelong dynamics and exposure to sex steroids differ greatly between sexes: men 
experience an age-related linear decline in testosterone levels whereas women’s lives are 
characterized by constant periodic fluctuations including menarche, the menstrual cycle, 
pregnancies, and menopause. Consequently, when it comes to AL, the biological sex differences 
observed might depend on sex steroids (i.e., testosterone vs. estrogens), levels of sex steroids (i.e., 
phase of the menstrual cycle, pregnancy, menopause), and previous or lifelong exposures (i.e., age 
at menarche/puberty, number of pregnancies, age at menopause, exogenous administration such as 
hormonal contraceptive and replacement therapy). As differences in the hormonal milieu vary 
greatly between individuals throughout a lifetime, a simple dichotomized perspective of sex 
differences might be oversimplified. Incorporating validated measures of the most important 
dynamic variables not homogenously distributed across sexes could indeed refine the current 
dichotomous classification of sex. 
Men and women also differ in terms of their socialization, identity, and subjective roles 
that are expected of them within given socio-cultural periods (Lips, 2008). Gender or sex-roles 
refer to the implicit and explicit dissimilarities in an array of socio-culturally constructed roles and 
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relationships as well as sex-typical personality factors (e.g., assertiveness). To date, little is known 
of the impact of gender on stress, although various gender-specific and health-related behaviors 
confer a differential vulnerability or resilience to various diseases within and between societies 
(Courtenay, 2000). In terms of stress responsivity, a study found that men tend to benefit from 
their partner’s social support by secreting decreased cortisol levels when facing an acute stressor 
whereas women had an increased cortisol response in the presence of their partner but not in the 
presence of a stranger (Kirschbaum, Klauer, Filipp, & Hellhammer, 1995).  
Gender might also be linked to diverse patterns of threat processing and coping 
mechanisms. Indeed, women demonstrate increased cortisol levels when facing social rejection 
challenges whereas men tend to be more reactive when confronted with achievement-based 
stressors (Stroud, Salovey, & Epel, 2002). As tasks that elicit socio-evaluative threat induce HPA-
axis activations (Dickerson & Kemeny, 2004), differences in stress perception might be driven by 
social constructs and gender-based attributions. Substantiating this is a fascinating evolutionary 
argument hypothesizing that men and women cope differently to stress. Accordingly, the primary 
stress response pattern for men is the “fight-or-flight” response, whereas women might be more 
prone to engage “tend-and-befriend” mechanisms, such as nurturing and socializing behaviors that 
may protect against the demands of pregnancy, nursing, and child care (Taylor et al., 2000). This 
idea might shed some light on sex differences found in the AL literature that are moderated by 
social and relational factors. Taken from a developmental psychopathology perspective, 
interactions among sex and gender force us to reconsider how dichotomous and dimensional 
variables co-exist to affect a wide spectrum of behaviors, cognitions, and life-long propensities 
towards certain diseases.   
 
Allostatic load sex differences  
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The MacArthur studies provide evidence for age-specific sex differences in AL (Juster et 
al., 2010). High cortisol levels are associated with memory impairment in women (Seeman et al., 
1997a), while elevated noradrenalin levels relate to cognitive decline in men (Karlamangla, 
Singer, Chodosh, McEwen, & Seeman, 2005a). Using advanced statistical techniques to tease 
apart biomarker combinations demarcating 12-year mortality risk between the sexes, Gruenewald 
and colleagues (2006) found that high risk pathways of biomarker clustering for men included 
adrenalin, noradrenalin, interleukin-6, C-reaction protein, and fibrinogen, while for women 
included interleukin-6, C-reactive protein, HbA1c, and systolic blood presure (Gruenewald et al., 
2006). Interestingly, elevated systolic blood pressure occurred in 100% of female high-risk 
pathways but only 17% for male high-risk pathways principally dominated by elevated fibrinogen, 
noradrenline, and adrenalin levels otherwise completely absent for females.  
Such “biological signatures” demonstrate that there are multiple sex specific routes 
whereby exacerbated biomarkers lead to AL and mortality risk. In an earlier analysis, however, 
cardiovascular biomarkers were more often dysregulated for males, while neuroendocrine 
biomarkers were more often dysregulated for females (Seeman, Singer, Ryff, Dienberg Love, & 
Levy-Storms, 2002). These findings from the same cohort measured at different time-points reveal 
that AL pathways indeed differ between the sexes, although sex-specific biomarker clusters 
depend on age and perhaps sex hormones levels. Note that AL sex differences may not be as 
easily detected in younger cohorts. For instance, a recent 15-year follow-up study using the 
Coronary Artery Risk Development in Young Adults (CARDIA) study did not find evidence for 
sex nor ethnicity differences in forty year old participants on average (Seeman et al., 2009). 
Noteworthy is that the authors’ application of structural equal modeling of AL biomarkers 
accounted for as much 84% of explained variance among heart rate variability, blood pressure, 
inflammatory, metabolic, catecholaminergic, and GC meta-factors. It would be interesting to see 
    Transdisciplinary Allostatic Load Review 
	   43 
how clusters of AL biomarkers differ between the sexes in follow-ups of other cohort studies, and 
to what extent the social and cultural environment moderates potential effects throughout the life 
cycle.   
Early life experiences, SES, and ethnicity further moderate AL among the sexes. 
Retrospective reports of positive parental bonding, harmonious later life relationships and the 
presence of a spouse are associated with lower AL in elderly men who benefit most from 
emotional support (Seeman et al., 2004; Seeman et al., 2002). On the other hand, low SES results 
in elevated levels of AL in African American women (Geronimus, Hicken, Keene, & Bound, 
2006) and female sex leads to higher AL with higher type II diabetes risk in American Samoan 
women (Crews, 2007). Social ties with close friends is protective in both elderly women and men 
(Seeman et al., 2004), while concurrent and cumulative perceived stress increases AL in both 
sexes, but it is most strongly expressed in women (Goldman et al., 2005). Interestingly, decreased 
AL levels have been reported in women but not men who regularly attend religious services 
(Maselko, Kubzansky, Kawachi, Seeman, & Berkman, 2007) and who have a greater sense of 
coherence and meaningfulness in life (Lindfors, Lundberg, & Lundberg, 2006). These studies 
highlight the importance of sex in the assessment of AL biomarkers and perhaps as well to the 
existential and spiritual benefits conferred on particular gender-typed behaviors.  
Taken together, such findings corroborate important interactions known to exist between 
spiritual factors such as sense of purpose, meaningfulness, connectedness, and other health 
domains (Picard et al., 2011) within the context of social and cultural elements. While these 
findings corrorabrate existing literature (Seeman, Dubin, & Seeman, 2003), much concerning such 
multi-faceted interactions in relation to psychopathology remain to be elucidated. Most 
importantly, we must highlight that no AL studies have measured sex hormones, although their 
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potential implications in various AL stages and disease trajectories is critical, as are their role in 
these sex differences.  
 
Male sex hormones 
Starting at the 3rd to 4th decade of life, testosterone (T) levels in men generally decrease at 
a proportion of 1 to 2% per year (Feldman et al., 2002).  It is now well known that androgen levels 
have a series of impacts on different biological systems. Beyond reproductive functions, male sex 
hormones interact and even regulate some of the AL primary mediators and secondary outcomes 
that could potentially lead to some serious issues, especially in hypogonadal men.  
The HPA-axis has an inhibitory effect on the hypothalamic-pituitary-gonadal (HPG)-axis 
at the detriment of reproductive behavior and other HPG tract functions (Viau, 2002). In humans, 
increased GCs levels impair the expression of the luteinizing hormone-releasing hormone 
(LHRH), the secretion of luteinizing hormones (LH) and the synthesis of sex steroids like T 
(Rivier & Rivest, 1991; Tilbrook, Turner, & Clarke, 2000). However, the relationship between 
these two endocrine systems is not unidirectional. While cortisol has inhibitory effects at all three 
levels of the HPG-axis, T itself inhibits HPA-axis activity at the hypothalamic level (Terburg, 
Morgan, & van Honk, 2009), exerting a strong influence on GC regulation that may modulate sex 
differences in stress-related HPA activity (Kerr & Kerr, 2001; Kornstein et al., 2000). In a variety 
of species, it is well known that males show lower ACTH and GC levels in both basal and stress-
induced HPA-axis activity due, in part, to the inhibitory effects of T (Handa, Burgess, Kerr, & 
O'Keefe, 1994a; Young, 1998). Moreover, in a male rat model of stress, gonadectomy increases 
ACTH and corticosterone responses to acute stress while 5-alpha-dihydrotestosterone (5α-DHT) 
replacement reverses this effect; this modulatory effect has not, however, been addressed under 
conditions of chronic stress (Handa et al., 1994b).   
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There is also a strong relation between T and cytokine production. Normal aging is 
associated with increasing levels of cytokines including interleukin-6 (IL-6) and tumor necrosis 
factor-alpha (TNF-α) during the same time period as age-related T decreases. There is evidence 
that both IL-6 and TNF-α have an influence on the three levels of the HPG-axis, resulting in 
impaired synthesis and release of T (Maggio et al., 2005; Mealy, Robinson, Millette, Majzoub, & 
Wilmore, 1990). Indeed, higher plasma cytokine levels have been observed in men with lower 
androgen levels (Pugh, English, Jones, & Channer, 2000). On the other hand, testosterone 
treatment has been reported to reduce the quantity of circulating pro-inflammatory cytokines. In 
an in vitro and in vivo experimental study, Pugh and coworkers (2000) found that androgens 
suppress macrophage production of cytokines and that gonadotropin therapy reduces the high 
levels observed in hypogonadal men. These findings suggest that exogenous T may be used as a 
potential anti-inflammatory, although further research must be done to confirm the causality 
between inflammatory markers and T in aging men.  
In terms of secondary outcomes, T deficiency has been shown to alter vascular smooth 
muscle reactivity, which results in vasoconstriction (Traish, Guay, Feeley, & Saad, 2009a) and is 
further shown to result in significant reductions in blood pressure in 66 hypogonadal men with 
intramuscular testosterone therapy (Zitzmann & Nieschlag, 2007). Several studies have also 
reported that low T levels are associated with increased total cholesterol and LDL-cholesterol, 
while androgen treatment results in a favorable lipid profile. T additionally has a positive 
association with HDL-cholesterol levels, although there are some discrepancies when it comes to 
remediation by means of T treatment (Traish, Saad, & Guay, 2009c). Low T levels also 
correspond to elevated insulin, glucose, and HbA1c levels, which are reversed by androgen therapy 
(Traish, Saad, Feeley, & Guay, 2009b). Several studies demonstrate that T supplementation in 
hypogonadal middle-aged men leads to a significant reduction of visceral fat, that acts like an 
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endocrine organ promoting cytokine production, and a decrease of plasma insulin levels and 
increased glucose concentrations (Marin et al., 1992a; Marin, Krotkiewski, & Bjorntorp, 1992b; 
Rebuffe-Scrive, Marin, & Bjorntorp, 1991). A host of studies have come to conclude that 
clinically reduced T plasma levels lead to a higher risk of developing type-II diabetes, insulin 
resistance, obesity, atherosclerosis, metabolic syndrome, and cardiovascular disease (Traish et al., 
2009b). In sum, androgen deficiency is associated with many pathophysiological states that 
modulate increased AL.   
At a neurological level, T also acts as an endogenous neuroprotective factor in men 
independently from estrogen. Androgens promote neuron viability during neural development. In 
adult brains, T treatment enhances nerve regeneration and attenuates neuron loss following injury 
or disease-related toxicity, especially in motor neurons (Jones, Pugh, Hall, Channer, & Jones, 
2003). In addition, androgens play a protective role in neuron survival in brain areas including the 
hippocampus and cortical regions particularly vulnerable to neurodegenerative diseases such as 
Alzheimer’s disease (Simerly, Chang, Muramatsu, & Swanson, 1990), functioning as an anti-
aging agent with beneficial regulation of pathogenic β-amyloid accumulations.  
While there are still some inconsistencies in the literature, endogenous T levels effect 
cognition with reports of impaired memory and visuo-spatial functions in middle-aged and elderly 
men with lower T levels and conversely enhanced attention, executive function, processing speed, 
and global cognition in individuals with higher T levels (Warren, Serby, & Roane, 2008). In a 
cross-sectional study with 400 men between the ages of 40 and 80, a curvilinear association 
between T and memory performance and processing capacity was observed in the oldest group 
pointing to an optimal sex hormone level for cognitive functioning, although no explanatory 
mechanism has been proposed (Muller, Aleman, Grobbee, de Haan, & van der Schouw, 2005).    
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A relationship has also been observed between androgen deficiency and symptoms of 
major depression such as weakness, fatigue, insomnia, irritability, lack of concentration, and 
memory impairment. Although it is not clear that androgens have a direct effect on the 
development or maintenance of major depressive disorder, prevalence rates are higher in 
hypogonadal men (Amore, 2005). Furthermore, low testosterone values are associated with male 
depressive illness while androgen therapy seems to have antidepressant proprieties. It has been 
proposed that the heterogeneity in T acts on the HPA-axis and may explain the variability in 
individual resistance to antidepressant treatment (Holsboer & Barden, 1996). These results 
identify a potential mechanism for the variability in psychopharmacological responsivity that 
should be explored further.  
T levels may also play a crucial role in other psychiatric conditions, such as antisocial 
personality disorder (APD) and psychopathy. A large body of evidence has established the 
testosterone-cortisol ratio as a potential marker for aggressive tendencies. Indeed, high T levels 
combined with low cortisol values lead to more attention towards anger and confrontation, less 
inhibition of aggressive behavior, and less experienced fear (Terburg et al., 2009). These factors 
overlap with APD and psychopathy symptomatology and the ratio imbalance may be one of the 
mechanisms explaining social aggression in this personality disorder. Pharmaceutically 
readjusting and maintaining balanced T and cortisol levels might reduce antisocial and aggressive 
behaviors.  
In summary, there is considerable evidence that T can be beneficial, especially in middle-
aged and elderly men as well as individuals suffering from hypogonadism. T replacement therapy 
may offer hope in improving numerous clinical conditions, as T influences AL at every level of 
dysregulation starting with primary mediators like GCs and cytokines, right through to tertiary 
outcomes including, among others, cardiovascular disease, type-II diabetes, atherosclerosis, and 
    Transdisciplinary Allostatic Load Review 
	   48 
Alzheimer’s disease. On the other hand, we must be very cautious in arriving at any hasty 
conclusions before further research establishes the specific role androgens exert on many 
interconnected biomarkers, modulators, and outcomes assessed using the AL model. At a 
transdisciplinary level, documenting time course patterns of interactions between T with respect to 
other life domains may yield important insights into the global health implications of abnormal T 
levels.  
 
Female sex hormones 
 Like T, estrogens (E) have essential biological effects on many physiological processes. 
Although E are traditionally connected with female reproduction, the importance of these 
hormones in non-reproductive processes such as cardiovascular health, immune functioning, bone 
synthesis, and brain morphology has also been implicated with a plethora of mechanisms towards 
disease pathways. 
There are several interactions between E and stress hormones that potentiate 
neuroprotection from cumulative stress perception and consequent HPA-axis dysregulation. The 
mechanisms underlying the cross talk between the gonadal and adrenal axis remain elusive, but 
evidence suggests that E might counteract the potentially damaging actions exerted on neural 
integrity and functioning (McEwen, 2002a).   
Acute stimulation of the HPA-axis by either a physical or psychosocial stressors suggests 
that E regulation may help explain the differential reactivity often observed between men and 
women. Men tend show a higher cortisol increase than women when performing a psychosocial 
stress task (Kajantie & Phillips, 2006); however, results are mixed when physical stressors and 
pharmacological challenges are employed (Kirschbaum, Wust, & Hellhammer, 1992; Roca et al., 
2005; Uhart, Chong, Oswald, Lin, & Wand, 2006). Another consideration is that HPA-axis 
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activities generally increase with ageing, sometimes so much so that this effect can be three times 
stronger in postmenopausal women compared to older men (Otte et al., 2005). Furthermore during 
the menstrual cycle, E and progesterone vary greatly and the use of a hormone-based 
contraceptive pill or menopause-related hormone therapy can impact stress reactivity (Bouma, 
Riese, Ormel, Verhulst, & Oldehinkel, 2009; Kajantie & Phillips, 2006; Kirschbaum, Kudielka, 
Gaab, Schommer, & Hellhammer, 1999; Kirschbaum, Pirke, & Hellhammer, 1995; Komesaroff, 
Esler, & Sudhir, 1999; Marinari, Leshner, & Doyle, 1976; Patacchioli et al., 2006; Prinz, Bailey, 
Moe, Wilkinson, & Scanlan, 2001). While evidence is scarce, particularly concerning 
progesterone, it does seem that E has beneficial effects on dampening the HPA-axis, although 
much more research is needed before drawing any conclusions (Kajantie & Phillips, 2006). 
Differential stress responses observed between sexes and at different hormonal states 
might depend on the nature of the stressor. One explanation is that each stressor has a different 
route that triggers the HPA-axis. Psychosocial stressors involve the limbic system since it is based 
on the conscious interpretation of the situation whereas physical stressors trigger the 
hypothalamus, while pharmacological challenges can impact all three levels of the HPA-axis 
depending on the agent used (Dedovic, Duchesne, Andrews, Engert, & Pruessner, 2009).  
 Interestingly, brain structures involved in the interpretation of a stressor and regulation of 
the HPA-axis are also rich in E receptors that are responsive to different E levels and are sex-
dimorphic in terms of developmental programming. For example, the hippocampus is involved in 
the appraisal and contextualization of stress, is essential when sorting memories under stress, and 
is structurally sensitive to the neurotoxic effects of cortisol. As E have neuroprotective effects, 
hormone therapy (HT) following menopause can protect the integrity of the hippocampus in a 
duration- and potentially time-dependent manner.  
 It has been observed that women using HT have larger HVs than non-users and men 
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(Eberling et al., 2003; Lord, Buss, Lupien, & Pruessner, 2008). This sexual dimorphism suggests 
that sex and/or gender and sex steroids may have a significant impact on HPA-axis regulation and 
AL levels as one ages (for a review, see (Wolf & Kudielka, 2008). In order to resolve this issue 
and hopefully develop individualized approaches to health prevention and care, studies 
investigating multiple levels of outcomes that interact with the aforementioned variables are 
needed. 
 Like T, the primary immunological mediators of AL are particularity sensitive to E 
regulation. E play a role in the sex difference characterizing many conditions with inflammatory 
components including stroke, bone metabolism, Alzheimer's and Parkinson's diseases, and even 
chronic autoimmune diseases such as multiple sclerosis and rheumatoid arthritis. Whether E have 
protective anti-inflammatory effects or pro-inflammatory properties is uncertain. Indeed, 
translating animal and in-vitro results on modulatory effects of E on cytokines to the human 
condition is particularly difficult and complex since the site of action (cells, organs), E dosage 
administered, compound studied (17β-estradiol vs. conjugated E), sex, menstrual cycle, 
pregnancy, menopausal status, exogenous administration (i.e., contraceptive pill, HT), and age all 
have significant impacts on the effects and interactions observed (Cutolo, Capellino, & Straub, 
2008; Cutolo & Straub, 2009; Cutolo et al., 2004; Hughes & Clark, 2007; Pfeilschifter, Koditz, 
Pfohl, & Schatz, 2002; Rossouw et al., 2008). Interestingly, evidence suggests that a time-
dependent modulatory effect of E on cytokines occurs with increased risk of CVD around 
menopause and hot flashes and accelerated phase of bone loss being limited to the first 5-10 years 
following menopause (Kronenberg, 1990; Maxwell, 1998; Pfeilschifter et al., 2002). Other 
pathways accounting for sex differences in several AL-related conditions involve differential 
lipidic and glycemic functions suggesting that E exert a lifetime modulatory role on related 
pathologies (e.g., diabetes, obesity).  
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 E levels are notoriously linked to cardiovascular risk at early as well as old age. Sex 
hormones appear to modulate lipid levels, especially HDL-cholesterol and insulin resistance in 
pre-pubescent children and adolescents (Agirbasli et al., 2010). Moreover, E have beneficial 
effects on lipid metabolism by decreasing low-density lipoprotein (LDL)-cholesterol and 
increasing HDL cholesterol. HT studies that examine postmenopausal women converges towards 
a protective role of E against CVD (O'Brien & Nguyen, 1997). However, randomized controlled 
trials such as the Heart and Estrogen/Progestin Replacement Study (HERS) and the Women’s 
Health Initiative (WHI) study led to unexpected and puzzling results: women with coronary heart 
disease (CHD) in the hormone group had a higher risk of CHD events during the first year 
followed by a decrease during year 3 to 5 and no effect after nearly 7 years (Grady et al., 2002).  
 The WHI results have been widely interpreted as demonstrating that combined HT has no 
beneficial effect and may even increase CVD. These controversial results were in disagreement 
with results from large epidemiological studies that showed protection by HT. This led researchers 
to believe that women in the observational studies must have initiated HT at or near the 
menopausal transition. Indeed, treatment in the WHI studies started 12 years after menopause, 
such that beneficial effects of E could only be observed if treatment was initiated during the 
menopausal transition before damages linked to E deficiency were present and potentially 
irreversible, therefore rendering HT more harmful than beneficial in later life (Harman et al., 
2005a; Harman, Naftolin, Brinton, & Judelson, 2005b; Low et al., 2002; Miller et al., 2009; 
Rossouw et al., 2007). It is important that future research address this controversy.  
 E are also involved in insulin regulation and glucose metabolism, although mixed results 
prevent any conclusions. Both endogenous and exogenous E are known to influence insulin 
sensitivity across the menstrual cycle, during pregnancy, in the menopausal transition, and in 
relation to hormonal contraception and HT (Bruns & Kemnitz, 2004). Menopause, in particular, 
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effects body composition in some women, which in turn is associated with impairments in glucose 
metabolism and insulin sensitivity. Whether E effects on glycemic regulation depend on body 
composition changes and/or age is unknown (Bruns & Kemnitz, 2004; Szmuilowicz, Stuenkel, & 
Seely, 2009). 
 Several studies have documented E effects on cognitive functions (e.g., learning and 
memory), on mood states, as well as on neurodevelopmental and neurodegenerative conditions. E 
have neuroprotective properties ranging from decreased neuronal loss, neurogenesis, 
neurotransmission, synaptic plasticity and dendritic spine density and connectivity (Behl, 2002; 
McEwen, 2002a). Moreover, E may impact brain metabolic states by enhancing glucose transport 
and cerebral blood flow, which are markedly altered in Alzheimer’s disease (Eberling, Reed, 
Coleman, & Jagust, 2000; Greene, 2000; Maki & Resnick, 2000). Cognitive functions are indeed 
sensitive to the effects of E, as differences are found during the menstrual cycle, pregnancy, 
menopausal transition, and upon use of HT later in life (Ancelin & Ritchie, 2005; Sherwin, 2007). 
Timing of HT initiation following menopause and duration of treatment may also be important 
factors to consider when delineating effects of estrogens on cognitive functions (MacLennan et al., 
2006).  
 Increased endogenous E exposure appear to decrease the risk of AD, with later age at 
menarche increasing the risk of developing AD later in life (Paganini-Hill & Henderson, 1994). 
Interestingly, females carrying the E4 allele of the ApoE gene with longer reproductive periods are 
at even greater risk of dementia (Geerlings et al., 2001). Furthermore, women who undergo 
menopause surgically are at increased risk of cognitive impairment or dementia, the risk of which 
increases the earlier the surgery was done (Rocca et al., 2007). Several studies have even found 
that reproductive events in a woman’s life, such as age of menarche, the postpartum period, and 
menopause can increase the risk of developing psychiatric conditions (Bennett, Einarson, Taddio, 
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Koren, & Einarson, 2004; Brandes, Soares, & Cohen, 2004; Pigott, 2003; Ross & McLean, 2006; 
Steiner, Dunn, & Born, 2003). For instance, an analyses of the NHANES cohort found that earlier 
age of menarche was associated with increased AL levels (Allsworth, Weitzen, & Boardman, 
2005). As women have heightened vulnerability for developing specific mood disorders like 
depression, it will be important that future AL studies take female sex hormones into 
consideration. This will help reveal the degree to which female sex hormones interact with other 
processes to influence key biological and psychological outcomes. 
 
Conclusion and future directions 
 These results collectively suggest that AL trajectories might be effected by differences 
stemming from sex, gender, and lifelong interactions to sex steroid exposures. It is hypothesized 
that if gender inequalities could be decreased or even eliminated, sex differences would no longer 
exist in these conditions (Lips, 2008). To better understand sex differences in AL, special attention 
must be directed toward the differential socio-cultural and biological contexts of individuals. An 
important challenge will also be to understand the dynamic interactions among sex and gender 
differences in psychopathologies throughout lifespan development that change throughout history. 
For instance, cardiovascular disease, once a predominantly male pathology, now claims at least 
41% of all deaths of Canadian women in comparison to 37% for men (Plotnikoff, 1997). This 
could be partially explained by the fact that women have increased their participation in the 
workforce by 126% over the last 30 years (World-Bank, 2001) and now represent 42% of the 
entire global labor force (ILO, 2000; WHO, 1999).  Perhaps this equitable progress has had a 
physiological price. Higher levels of stress for working women who must balance multiple work-
family roles and responsibilities can indeed further strain their health and well-being (Lagerlof, 
2005). By applying a transdisciplinary approach that elucidates how sex, gender, and sex 
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hormones interact within the context of society as a whole, we will be adding an important piece 
to the puzzle addressing AL sex differences.   
 In the first part of this review article, we have explored how early life adversities, genetics, 
environmental toxins, and sex differences can influence AL levels throughout lifespan 
development. Now in the second part, models of AL will be discussed for three psychological 
circumstances; namely, severe mental illnesses like schizophrenia and bipolar disorder, the 
dementia spectrum, and caregiving. These three experiences represent unique “experiments of 
nature” whereby AL manifests itself respectively by means of pharmacological remediation, 
pathological aging, or by virtue of helping others at personal detriment. Beginning with severe 
mental illness, we shall elucidate potential mechanisms whereby healing the distressed mind can 
be hurtful for the body. 
 
Schizophrenia and Bipolar Disorder 
 The AL index could be particularly powerful in identifying schizophrenic or bipolar 
patients at high-risk of developing serious co-morbidities due in part to pharmacology and 
behavioral compensation. As this section will elaborate, we believe that the AL index could be a 
useful monitoring tool to facilitate and implement preventive care in these severe mental illnesses 
(SMI). The AL index could additionally be used to assess long-term side-effects of 
pharmacological treatment and complex intervention programs, as no tool to achieve this goal is 
currently available. We first review physiological correlates of schizophrenia and bipolar disorder 
within an AL framework, followed by pharmacological reversals of these dysregulations, and then 
conclude with how pharmacology can provoke co-morbidities.  
 
Physiological dysregulations in severe mental illness 
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Individuals with SMI are at increased risk of physiological dysreguations. No studies have 
assessed AL indices vis-à-vis schizophrenic and bipolar patients (for an excellent theoretical 
review, see Kapczinski et al., 2008); however, a review of individual biomarkers suggests that it 
could be a useful and easily constructed measure of multi-systemic functioning throughout the 
disease courses. In considering primary mediators of AL, increased basal HPA-axis activity can be 
found across different pathological stages in schizophrenia and bipolar disorder (Gallagher, 
Watson, Smith, Young, & Ferrier, 2007; Linkowski et al., 1994). Across the board, higher 
baseline cortisol levels have been reported in drug-naive first-episode patients with schizophrenia 
(Muck-Seler et al., 2004; Walsh, Spelman, Sharifi, & Thakore, 2005) as well as in medicated 
(Gallagher et al., 2007; Ritsner et al., 2007) and in chronic schizophrenic patients (Yilmaz et al., 
2007).   
In contrast to basal activity, findings focused on HPA reactivity assessed by the 
dexamethsone suppression test in schizophrenic patients are less consistent: both increased 
(Muck-Seler, Pivac, Jakovljevic, & Brzovic, 1999) and decreased reactivity (Ismail, Murray, 
Wheeler, & O'Keane, 1998) are reported. Conversely, in bipolar patients, elevated reactivity has 
been found (Sher, 2006) regardless of the phase of the illness (Watson, Gallagher, Ritchie, Ferrier, 
& Young, 2004). Interestingly, the persistence of abnormal HPA-axis reactivity has also been 
observed in a portion of patients in remission who are at higher risk of depressive relapse (Vieta et 
al., 1997).  
One potential pathophysiological pathway linking cortisol release to schizophrenic 
symptoms is via its interference with dopamine functioning prominently implicated in psychotic 
symptoms. Cortisol secretion augments dopamine neurotransmission (Czyrak, Mackowiak, 
Chocyk, Fijal, & Wedzony, 2003; Dallman et al., 2004; Marinelli, Rudick, Hu, & White, 2006; 
Moghaddam, 2002; Pruessner, Champagne, Meaney, & Dagher, 2004) and the HPA-axis and 
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dopaminergic neurocircuitry appear to reciprocally activate each other (Walker, Mittal, & Tessner, 
2008). Consistently, higher cortisol responses to amphetamines are related to more positive 
subjective drug effects, higher ratings of positive drug effects, and greater dopamine release in 
normal individuals (Oswald et al., 2005). 
DHEA represents another primary mediator of AL that acts as a functional HPA-axis 
antagonist (Maninger, Wolkowitz, Reus, Epel, & Mellon, 2009). The DHEA-to-cortisol ratio in 
chronic schizophrenia patients is negatively correlated with the duration of illness (Maninger et 
al., 2009). Moreover, decreased DHEA levels are associated with the severity of disease and 
cognitive impairment while medication might normalize levels. In the bipolar population, research 
is scarce, with only one report of normal DHEA levels (Gallagher et al., 2007). In sum, 
abnormalities in HPA-axis functioning in SMI patients seem to be characterized by increased 
basal cortisol levels, abnormal diurnal patterns of secretion, and dampened GC receptor signaling. 
Different cytokines also function as complex primary mediators that contribute to AL 
(Kapczinski et al., 2008). This is due in part to their interactions with the neuroendocrine system 
and involvement in mood regulation. For example, interleukin-2 (IL-2) can elicit positive and 
negative symptoms of schizophrenia in normal individuals, including hallucinations, distortions, 
impaired cognition, and fatigue (Denicoff et al., 1987). 
Individuals with schizophrenia have increased blood levels of IL-6, interleukin 1 receptor 
agonist (IL-1RA), soluble interleukin 2 receptor (sIL-2R) and decreased secretion of IL-2 by 
peripheral blood leukocytes (Potvin et al., 2008). In bipolar patients, elevations in IL1 receptor 
(IL1-R), IL-2R, IL-4, IL-6, IL-8, and a decrease in IL-2 have been identified (Breunis et al., 2003; 
Kim, Jung, Myint, Kim, & Park, 2007; Liu et al., 2004; O'Brien, Scully, Scott, & Dinan, 2006; 
Ortiz-Dominguez et al., 2007; Tsai et al., 1999). Based on these results, an ongoing “pro-
inflammatory syndrome” in both schizophrenic and bipolar patients may manifest itself. However, 
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it is difficult to distinguish between the relative influence of pathophysiological mechanisms 
inherent to SMI and other factors that influence cytokines levels, such as adiposity and, as will be 
discussed shortly, interactions with medications and associated biomarkers (Bob et al., 2010; 
Trayhurn & Wood, 2004).  
 
Pharmacotherapeutic factors in severe mental illness 
In the vast majority of cases, the treatment of schizophrenia and bipolar disorder relies on 
acute pharmacological interventions aimed at overt psychotic/affective  symptoms. These drugs 
have considerable potential to modulate ongoing allostatic processes (e.g., HPA-axis reactivity, 
immune regulation, neuroplasticity, cognitive functions, metabolic regulations) by antagonizing 
some while synergizing others.  
The following will discuss commonly established pharmacological classes of drugs, 
namely first-generation antipsychotics (FGA or typical), second-generation antipsychotics (SGA 
or atypical), mood stabilizing agents and different classes of antidepressants used in the treatment 
of SMI. SGIs dampen over-activation of the stress axis by reducing ACTH and cortisol levels in 
schizophrenic patients (Mann et al., 2006; Markianos, Hatzimanolis, & Lykouras, 1999; Ryan, 
Sharifi, Condren, & Thakore, 2004; Zhang, Zhou, Cao, Wu, & Shen, 2005) as well as in healthy 
individuals (Cohrs et al., 2006). Higher pretreatment cortisol levels have been related to higher 
antipsychotic responsiveness (Ritsner et al., 2005) and cortisol levels correlate with negative 
symptoms following withdrawal from SGAs (Zhang et al., 2005). 
 On the other hand, conflicting results exist regarding the effect of mood stabilizing agents 
such as lithium and carbamazepine on HPA-axis responsivity (Bschor et al., 2002; Watson et al., 
2004). Antidepressant drugs impact HPA-axis activation via diverse mechanisms of action 
(Horstmann et al., 2009; Schule, 2007). Interestingly, the potential of selective serotonin reuptake 
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inhibitors (SSRIs) to restore disturbed HPA-axis feedback control could be beneficial not only for 
patients with affective disorders (Walker et al., 2008) but also adolescents at clinical risk for 
psychosis. Indeed, some SSRIs appear to attenuate prodromal psychotic symptoms and reduce the 
risk of converting to axis I psychosis (Cornblatt et al., 2007). 
In addition, psychotropic drugs have important immunomodulatory effects. FGAs like 
haloperidol, chlorpromazine, and flupentixol inhibit certain aspects of lymphocyte proliferation in 
vitro (Baker, Santalo, & Blumenstein, 1977; Schleuning, Duggan, & Reem, 1989). In vivo data 
also indicate that antipsychotic medication may be responsible for the increases in IL-2R and 
decreases of IL-2 (Potvin et al., 2008; Zhang et al., 2009). These findings suggest that 
antipsychotic administration may have immunosuppressive effects (Maes, Meltzer, & Bosmans, 
1994).  
The potential to modulate neuroendocrine and immune regulation illustrates that the 
effects of psychiatric medications currently in vogue extend far beyond tuning doses in an isolated 
manner, one neurochemical system at a time. Rather, psychotropic agents can promote 
neuroprotective and neurotrophic processes involving multiple signaling pathways (Lieberman et 
al., 2008). For instance, patients treated with antipychotics have reduced oxidative stress 
(Dakhale, Khanzode, Saoji, Khobragade, & Turankar, 2004), lower levels of lipid peroxidation  
(Kropp et al., 2005), and specific SGAs might even be able to ameliorate gray matter loses in 
patients in the early stages (Lieberman et al., 2005; van Haren et al., 2007). 
Likewise, mood stabilizing and antidepressant treatments have also been consistently 
reported to influence neuroplastic processes (Hunsberger, Austin, Henter, & Chen, 2009). 
Neuroimaging studies in clinical populations reveal that lithium treatment is associated with an 
increase of grey matter in different limbic regions such as the anterior cingulate (Bearden et al., 
2007), hippocampus (Yucel et al., 2007), amygdala (Foland et al., 2008), as well as with regional 
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increases in N-acetyl aspartate (NAA), an index of neuronal viability (Moore, Bebchuk, Wilds, 
Chen, & Manji, 2000). Chronic administration of antidepressant agents have also been shown to 
increase hippocampal neurogenesis in animal models and prevent adverse effects of chronic stress 
exposure on the brain in the animal model (Hunsberger et al., 2009). In humans, antidepressant 
treatment may also increase BDNF levels in depressed patients (Shimizu et al., 2003). 
 Consistently, the neuroplastic potential of psychiatric medications appears to be paralleled 
by clinically relevant cognitive improvements. A number of clinical and multicenter trials have 
reported that SGAs improve various cognitive symptoms in schizophrenic patients (Cornblatt et 
al., 2002; Harvey et al., 2004; Potkin, Fleming, Jin, & Gulasekaram, 2001; Schuepbach, 
Keshavan, Kmiec, & Sweeney, 2002; Stip et al., 2003), but effects are less pronounced using 
FGAs (Bilder et al., 2002; Green et al., 2002). These findings indicate that pharmacological 
interventions may decelerate, halt, and even reverse the detrimental cognitive processes found in 
SMI. Unfortunately, where psychiatry can positively take away, it can also negatively give in the 
form of diverse side-effects that can manifest themselves as secondary and tertiary outcomes. 
Such pharmaceutically induced conditions contribute to distressing rates of co-morbidities that 
exacerbate AL levels further in SMI patients. 
Antipsychotics are associated with an increased risk of developing the metabolic syndrome 
via weight gain, abnormalities in lipids, and glucose metabolism. Antipsychotic agents differ 
significantly in their potential to cause clinically relevant weight changes (>7% increase)(Haddad 
& Sharma, 2007). There are several mechanisms proposed to explain the weight gain related to the 
antipsychotic treatment. Firstly, a common side-effect of antipsychotics is increased appetite 
(Kroeze et al., 2003; Muller, Muglia, Fortune, & Kennedy, 2004) due to genetic mechanisms 
(Ellingrod et al., 2005) and impaired molecular actions (Allison et al., 1999; Elman, Borsook, & 
Lukas, 2006). Secondly, due to the their sedative effects, antipsychotics contribute to decreased 
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physical activity and energy expenditure (Lublin, Eberhard, & Levander, 2005). Last, SGAs can 
further deteriorate pre-existing hedonic interferences with the opioidergic system in schizophrenic 
patients (Elman et al., 2006). 
On the other hand, no weight gain is observed in about 25% of cases of metabolic 
syndrome under antipsychotic treatment, suggesting that other antipsychotic-induced metabolic 
disturbances might be at play (Newcomer, 2005). In a Finnish cohort study (Saari et al., 2004), it 
was concluded that patients on antipsychotic medications were 3-times more likely to have 
elevated cholesterol and triglycerides profiles than non-medicated control subjects. In addition to 
lipid profiles, antipsychotics may directly affect pancreatic functions and induce glucose 
abnormalities (Haddad & Sharma, 2007). Literature regarding adverse metabolic effects of mood 
stabilizers and antidepressants is currently less comprehensive. Nonetheless, treatment with major 
mood stabilizers like lithium (Vendsborg, Bech, & Rafaelsen, 1976), valproate, and 
carbamazepine (Swann, 2001) are associated with weight gain. That pharmacotherapy can act as 
both antidote and venom represents the difficulties of altering the biological functioning of 
selected systems without contaminating others. The reader will remember that these effects are a 
central criticism addressed by the allostasis concept that cautions against the dangers of 
iatrogenically inducing illness in patients.  
 
Iatrogenic effects and pharmaceutical allostatic load 
In addition to negative physiological effects, several psychotropic agents seem to interact 
with illness-related predispositions to synergistically worsen some unhealthy lifestyle behaviors 
and ultimately induce a “pharmacological” AL. We define pharmaceutical AL (PAL) as the 
adverse iatrogenic (“brought on by the healer”) effects medications can exert that then 
inadvertently prompt individuals to remediate the biological system(s) effected by unhealthy 
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means (e.g., smoking (see Figure 5), substance abuse). Current evidence points to three critical 
neurochemical systems that influence PAL: the (1) acetylcholinergic, (2) dopaminergic, and (3) 
opioidergic systems. 
Firstly, activity of cholinergic circuitry (e.g., nicotinic and muscarinic receptors) is related 
to memory and attention capabilities. Many psychotropic agents are known to antagonize 
muscarinic receptors (Minzenberg, Poole, Benton, & Vinogradov, 2004) that can inadvertently 
induce cognitive perturbations for countless schizophrenic patients (Minzenberg et al., 2004). 
Patients are therefore very likely to engage in behaviors that temporarily re-regulate these 
impairing symptoms. Such iatrogenic cognitive impairments only add to the already pre-existing 
perturbations of the cholinergic system found in schizophrenic patients. Importantly and 
unfortunately, nicotine can counteract these PAL induced cognitive dysfunctions (Levin, Wilson, 
Rose, & McEvoy, 1996), which might explain why psychiatric patients extensively self-medicate 
when treated with anti-cholinergics. 
Secondly, dopamine D2 receptor antagonists central to antipsychotic dampening of 
positive symptoms (i.e., delusions, hallucinations) due to excessive dopamine levels are also 
linked to well-known extrapyramidal (i.e., akathisia, dyskinesia, dystonia), endocrine (i.e., 
hyperprolactinemia), and a host of other side-effects. As evidenced by pharmacological studies in 
a healthy sample, haloperidol (a FGA and potent D2 receptor antagonist) administration causes 
psychomotor slowing and impaired executive function (Peretti et al., 1997) as well as sustained 
attention deficits and decreased self-reported quality of life (Saeedi, Remington, & Christensen, 
2006). This latter negative impact on affective regulation is consistent with reports of dysphoric 
responses occurring during antipsychotic treatment in psychiatric populations (Voruganti & 
Awad, 2004).  
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Differential potency of FGA and SGA to induce dopamine deficits seems to be clinically 
important, as illustrated by lower rates of substance abuse (Noordsy & Green, 2003) in patients 
treated by clozapine (a SGA) compared to FGAs. Furthermore, D2 receptor blocking in the 
striatum might increase risk of addictive behaviors (Krystal et al., 2006). Pharmacological D2-
receptor modulation worsens pre-existing vulnerabilities towards increased tobacco smoking in 
psychiatric patients. In a prospective study, the potent D2-receptor blocking FGAs were associated 
with an increase in nicotine dependence, but not in SGAs (Kim, Han, Joo, & Min, 2010). 
Interestingly, treatment with aripiprazol, a partial agonist of the D2 receptor, reduces both nicotine 
dependence and cigarette cravings (Kim et al., 2010). Similarly, patients treated with clozapine 
display lower rates of smoking and higher rates of smoking cessation compared to those treated 
with FGA (McEvoy et al., 1995). It is noteworthy that nicotine has the potential to alleviate 
several physical side-effects related to D2 receptor blocking, such as akathisia (Yang, Nelson, 
Kamaraju, Wilson, & McEvoy, 2002), a syndrome of unpleasant restlessness. Consistently, 
schizophrenic patients self-report higher desires for “sensorimotor manipulation”, “need for 
stimulation” and score lower on “sociability” than normals (Barr, Procyshyn, Hui, Johnson, & 
Honer, 2008), suggesting that their motivations towards maladaptive behaviors represents PAL 
related to antipsychotic medications. 
 Thirdly, SGAs may increase opioidergic neurotransmission and subsequently alter the 
“liking” processes of reward systems, leading to hedonic preference for sweet and fatty foods 
(Elman et al., 2006). Once again, these inclinations toward diets that counteract the effects of 
medications contribute to increased rates of obesity and metabolic problems. While we must be 
cautious in deriving any conclusions given differences among specific agents, dosage regiments, 
and an overall paucity of evidence, it can nevertheless be postulated that interactions between 
psychotropic drugs and several important neurobiological mechanisms might drive PAL effects. 
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At the heart of these three neurochemical systems involved in PAL are interactions to regulate 
HPA-axis activity by dampening cortisol dynamics associated with SMI and medications.  
 In sum, pharmacological agents have neuroprotective and neurotrophic effects, but they 
can also aggravate pre-existing susceptibilities by PAL, which in turn contribute further to 
dysregulation of primary mediators, secondary outcomes, and co-morbid tertiary AL outcomes 
(e.g., substance abuse, cardiovascular disease, somatic complaints; see Figure 6).   
 
Conclusion and future directions 
   The concept of PAL is formulated here in the hopes of contributing greater understanding 
to the complexities of pharmacological remediation. That pharmacotherapy can act as a form of 
AL in interaction with behavioral compensation is an idea that could be explored further in line 
with current thinking coming from research on addiction (e.g., (Koob, 2008, 2009; Koob & Le 
Moal, 2008a, 2008b). In so doing, we do not wish to minimize the important achievements of 
psychiatry and pharmacotherapy in general. On the contrary, the aims of this section is to add 
extra pieces of knowledge to apply the AL model within the realm of clinical practice so as to 
refine our definitions of health and disease. Importantly, delineating the interactions among SMIs, 
psychopharmacology, and differential clusters of symptomatologies provides insights into the 
mechanisms and heterogeneity in disease courses so central to developmental psychopathology.  
Within the current paradigms surrounding SMI (as well as in other fields), research 
priorities, nosological classifications, treatment strategies, and social policies are illness-centered. 
As useful as these approaches are in identifying biomolecular correlates and vulnerability factors 
for SMI, they are often not incorporated within patient-centered approaches by focusing on 
pathology alone. The biggest caveat of this pathology-driven approach is that it misses out on the 
immense potential to promote resiliency factors associated with positive health in individuals 
    Transdisciplinary Allostatic Load Review 
	   64 
suffering from SMI. A positive consequence of embodying a transdisciplinary perspective is 
therefore to recognize the multiple levels (e.g., psychosocial, behavioral, genetic) of AL and to 
foster patients’ sense of competence and engagement in their own treatment. 
 The concept of top-down regulation of cognitive, autonomic and neuroendocrine function 
inherent to the AL model will provide a rationale to support emerging trends that reorient 
therapeutic strategies and emphasize the role of healthy lifestyle promotion, social support, and 
governmental policies (McEwen, 2008). Basing interventions on a partnership rather than a model 
where the patient is a passive consumer of healthcare will further encourage patients’ coping 
abilities, dignity, and the person taken as a whole within his/her environmental context (Mezzich, 
2010). 
 Because SMIs like bipolar disorder and schizophrenia increase AL, elucidating how key 
biomarkers are linked to symptomatologies - before and after interventions - necessitates person-
centered approaches that appreciate, for instance, gene-environment interactions or differential 
neurobiological development throughout the life cycle. In delineating these different trajectories, it 
is essential that we further identify specific biopsychosocial signatures of specific disease 
vulnerabilities in relation to AL. In this spirit, where dementia falls on the continuum ranging 
from normal to abnormal aging represents another research area to explore. The following section 
will review various sub-sets of dementia as pathways towards AL.   
 
Dementia(s): A Question of Biomarkers?  
Dementia is a spectrum whereby the most prevalent form is Alzheimer’s disease (AD). 
Those afflicted experience gradual degeneration of memory and other cognitive faculties 
(McKhann et al., 1984) presumably due to β-amyloid plaque accumulations and neurofribrillary 
tangles. In other cases, CVDs like stroke can cause vascular lesions in the brain that can result in 
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the manifestation of cognitive deficits found in vascular dementia (VaD) or mixed dementia when 
concurrent in AD patients. At a preclinical stage of dementia are individuals with mild cognitive 
impairment (MCI) that present with subjective cognitive complaints, corroborated 
neuropsychological deficits, but no functional or social deficits (Petersen et al., 1999). Of 
particular interest are the physiological dysregulations characterizing distinct conditions that 
typify normal from abnormal aging. 
 
Physiological dysregulations in dementia 
 While no studies to date have assessed AL vis-à-vis dementia, the cognitive declines 
found in the MacArthur cohort (Seeman et al., 2001; Seeman et al., 1997b) imply that it could be a 
useful tool for detecting biological signatures of certain forms of dementia over others. For 
instance, multisystemic dysregulations captured by the AL index are strongly linked to frailty 
(Fried et al., 2001; Gruenewald, Seeman, Karlamangla, & Sarkisian, 2009; Szanton, Allen, 
Seplaki, Bandeen-Roche, & Fried, 2009). It would be beneficial that future research investigate 
how primary mediators and secondary outcomes might lead to differential susceptibilities. 
The role of stress hormones in the etiology of dementia is controversial (see Table 3). 
While some research suggests that AD patients are hypersecretors of cortisol (Giubilei et al., 
2001), longitudinal studies are needed to solidify the causal direction of this association. For 
example, increased urinary noradrenalin levels correlate with cognitive decline in healthy elderly 
men (Karlamangla, Singer, Greendale, & Seeman, 2005b) and increased cortisol secretion in 
normal elderly are associated with cognitive declines in some studies (Greendale, Kritz-
Silverstein, Seeman, & Barrett-Connor, 2000; Karlamangla et al., 2005a; Lee et al., 2007a; Li et 
al., 2006; Lupien et al., 1994; Seeman, McEwen, Singer, Albert, & Rowe, 1997b) but not all 
(Csernansky et al., 2006; Kalmijn et al., 1998; Peavy et al., 2009)  
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Two studies (Csernansky et al., 2006; Swanwick et al., 1998) found that increased cortisol 
levels over the years were associated with cognitive decline in individuals with clinical dementia 
ratings of 0.5 that some consider to resemble MCI. Conversely, lower morning cortisol levels at 
baseline were associated with future cognitive decline in normal elderly who are E4 carriers for 
the ApoE gene (Gerritsen, Comijs, Deeg, Penninx, & Geerlings, 2009) and higher cortisol is 
associated with slower cognitive decline in MCI (Peavy et al., 2009). Some studies found an 
association with cognitive decline later on in AD patients (Huang et al., 2009; Umegaki et al., 
2000; Weiner, Vobach, Olsson, Svetlik, & Risser, 1997), but not in individuals with CDR 1,0 or 
more (Csernansky et al., 2006; Swanwick et al., 1998). Taken together, these findings suggest that 
high cortisol levels lead to differential risk-profiles depending on whether individuals are ApoE4 
carriers, and whether they suffer from MCI or AD. They do not, however, provide sufficient 
evidence to make any conclusions regarding the role of stress hormones in dementia. 
Turning to another primary mediator of AL, no studies have found associations between 
dehydroepiandrosterone sulfate (DHEA-S) and dementia incidence (Barrett-Connor & Edelstein, 
1994; Berr, Lafont, Debuire, Dartigues, & Baulieu, 1996; Ponholzer et al., 2009), cognitive 
decline in normal elderly (Kalmijn et al., 1998), nor AD patients (Miller et al., 1998). DHEA-S 
may be predictive of general health declines and mortality for men (Barrett-Connor & Edelstein, 
1994; Berr et al., 1996).  
Regarding cytokines (see Table 4), some studies have found that dementia incidence is 
associated with IL-6 (Engelhart et al., 2004), CRP (Schmidt et al., 2002; Xu, Zhou, Zhu, Fan, & 
Liu, 2009), and TNF-α (Tarkowski, Andreasen, Tarkowski, & Blennow, 2003); however, negative 
results have been found concerning CRP (Engelhart et al., 2004; Gallacher et al., 2010; van den 
Berg, Biessels, de Craen, Gussekloo, & Westendorp, 2007) and IL-6 (Gallacher et al., 2010). 
Several studies have assessed the relations between baseline levels of inflammatory risk factors 
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and cognitive decline. Notably, people with higher basal levels of IL-6 in the MacArthur cohort 
were at greater risk of cognitive decline measured at baseline, 2.5 and 7 years later (Weaver et al., 
2002). Similarly, IL-6 was associated with cognitive decline for global measures of cognition 
(Alley, Crimmins, Karlamangla, Hu, & Seeman, 2008; Jordanova, Stewart, Davies, Sherwood, & 
Prince, 2007) or memory (Schram et al., 2007).  
Amidst the breadth of studies conducted using CRP, most have failed to find an 
association with global cognitive decline (Alley et al., 2008; Dik et al., 2005; Holmes et al., 2009; 
Hoth et al., 2008; Jordanova et al., 2007; Laurin, David Curb, Masaki, White, & Launer, 2009; 
Marioni et al., 2009; Schram et al., 2007; Yaffe et al., 2003). Exceptionally, increased CRP levels 
have been correlated with declines in executive functioning (Hoth et al., 2008) as well as in 
reasoning and memory abilities (Marioni et al., 2009). Using TNF-α, higher levels were not 
related to global cognitive decline in older individuals (Yaffe et al., 2003) but rather in AD 
patients (Holmes et al., 2009). Clearly, more research is needed in order to ascertain the 
association between dementia and/or cognitive decline vis-à-vis inflammation. Note that the most 
important confounder in these studies was the variability in the measure of cognitive declines. 
Several prospective studies have examined the metabolic syndrome (MetS) using the 
National Cholesterol Education Program (NCEP) criteria (Grundy, Brewer, Cleeman, Smith, & 
Lenfant, 2004) as predictors of dementia (see Table 5). Overall, results here too are mixed, with 
some positive (Muller et al., 2007; Solfrizzi et al., 2009; Solfrizzi et al., In Press) and negative 
(Forti et al., 2010; Raffaitin et al., 2009) findings linking MetS to dementia susceptibility. It 
appears that MetS is more consistently associated with cognitive decline (Ho, Niti, Yap, Kua, & 
Ng, 2008; van den Berg et al., 2007; Yaffe et al., 2007; Yaffe et al., 2004; Yaffe, Weston, 
Blackwell, & Krueger, 2009) than with clinical dementia. Other prospective studies have focused 
only on cardiovascular biomarkers of MetS, showing that vascular indices are linked to dementia 
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(Kalmijn et al., 1998; Kivipelto et al., 2006; Whitmer, Sidney, Selby, Johnston, & Yaffe, 2005) 
but not cognitive decline (Mielke et al., 2007; Xiong, Plassman, Helms, & Steffens, 2006). 
Notably, two studies have found that MetS is protective in individuals ages 75 and up 
against cognitive decline (van den Berg et al., 2007) and dementia (Forti et al., 2010). This may 
reflect the paradox effect, where the risk for dementia in relation to some cardiovascular risk 
factors seems to be inverted when measured in midlife compared to old age. Similar conclusions 
were made in a review by Schnaider and colleagues (2004) whereby hypertension and 
hyperlipidemia in midlife but not in late life were associated with increased risk of dementia 
(Schnaider Beeri et al., 2004). Regardless of age, diabetes was consistently associated with 
increased risk of dementia . These age-dependent associations might explain previous inconsistent 
results. 
 Another point for future investigations to consider is which biomarkers and outcomes to 
use. Studies demarcating dementia risk factors have found that MetS or vascular indices are 
predictors of VaD but not AD in elderly individuals (Kalmijn et al., 2000; Raffaitin et al., 2009; 
Solfrizzi et al., 2009). Yet, other studies suggest that cardiovascular risk factors might also be 
independently associated with AD. For instance, hypertension in midlife may (Kivipelto et al., 
2001) or may not (Luchsinger et al., 2005; Posner et al., 2002) be associated with AD. Skoog et al. 
(1996) found that hypertention at an older age is associated with AD but those who developed AD 
also showed bigger decline over the years previous to diagnosis (Skoog et al., 1996). Likewise, 
high total cholesterol is associated with AD when measured in midlife (Kivipelto et al., 2001) and 
old life (Notkola et al., 1998) but not in all studies (Li et al., 2005; Tan et al., 2003). Based on 
these inconsistencies, it can truly be said that biological signatures of dementia change as one ages 
and therefore cannot be considered finite.  
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 Consistent to this claim, one study found that total cholesterol levels of men with dementia 
- especially AD patients - declined 15 years prior to diagnosis and remained lower (Stewart, 
White, Xue, & Launer, 2007). Results are mixed as well for diabetes in old age vis-à-vis AD 
(Luchsinger et al., 2005; Xu et al., 2009). Finally for obesity in AD, both positive associations in 
older women (Gustafson, Rothenberg, Blennow, Steen, & Skoog, 2003) and negative associations 
(protective) in older individuals (Hughes, Borenstein, Schofield, Wu, & Larson, 2009) have been 
found.  In midlife, one study found that higher BMI was associated with future AD (Kivipelto et 
al., 2005), whereas baseline weight was not associated with AD in another study (Stewart et al., 
2005). Noteworthy for the latter study was that men with AD lost significantly more weight over 
the last 6 years previous to the diagnosis than men without dementia, potentially representing a 
phenomenon referred to as wasting in gerontology. 
 In sum, the transitions from normal into abnormal aging and dementia appear to be 
associated with distinct physiological features that constantly change as one continues to develop 
into old age. Disagreement on the precise biological correlates of specific disease states informs us 
that much more research is needed using a developmental psychopathological perspective in 
alliance with transdisciplinarism. Concordantly, the advantage of a multisystemic measure like the 
AL index in combination with neuropsychological assessment and neuroimaging, might prove 
fruitful in this endeavor, perhaps even more so than teasing apart complex configurations of 
biomarkers. Turning now to neuroimaging, it is important to highlight upon inception how 
individual differences when examining peripheral markers of AL in the body are only more 
complicated when observing lifecourse changes in the brain. 
 
Hippocampal volume in abnormal aging and dementia 
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Because hippocampal atrophy is an infamous feature of AD, much research has focused on 
how it corresponds to pathological aging. As a group, older adults generally have smaller HVs 
than young adults (Du et al., 2006; Resnick et al., 2000); however, there is substantial variation 
across age groups (Lupien et al., 2007). HV can predict cognitive decline among healthy older 
adults (Grundman et al., 2003; Jagust et al., 2006; O'Sullivan et al., 2009), therefore it might be a 
potential biomarker of pathological aging (Burgmans et al., 2009). We must be cautious, however, 
as it is difficult to ascertain whether HV is the chicken or egg in dementia. Among patients with 
MCI and AD, for instance, the hippocampus is one of the first regions to show atrophy (Dickerson 
et al., 2001; Jack et al., 1999; Jack et al., 1997) and MCI patients with smaller HVs progress more 
rapidly to AD (Korf, Wahlund, Visser, & Scheltens, 2004).   
As an important brain region in regulating the HPA-axis, the hippocampus is particularly 
vulnerable to GC neurotoxicity associated with AL. For example, elevated chronic life stress over 
a 20-year period was associated with decreased grey matter volume in the hippocampus and 
orbitofrontal cortex (Gianaros et al., 2007) and older adults with increasing cortisol levels over six 
years exhibit hippocampal atrophy and poorer memory performance (Lupien et al., 1998). Taken 
together, these results indicate the long-term impact of cortisol dysregulations and AL, and their 
association with poor cognition and hippocampal atrophy (McEwen, 2007a, 2008), although they 
also underline the complexity of teasing apart disease pathways when dealing with interconnected 
biomarkers.  
In addition to cortisol, chronic stress exposure increases the risk of developing insulin 
resistance and eventual type-II diabetes (Raikkonen, Keltikangas-Jarvinen, Adlercreutz, & 
Hautanen, 1996) linked to reductions in HV (Convit, Wolf, Tarshish, & de Leon, 2003), impaired 
memory performance (Convit, 2005; Gold et al., 2007; Hendrickx, McEwen, & Ouderaa, 2005) 
and, most importantly, increased risk for later AD onset (Arvanitakis, Wilson, Bienias, Evans, & 
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Bennett, 2004; Lee et al., 1999; Schnaider Beeri et al., 2004). There is cross-talk among these 
systems, as overactive HPA-axis activity is common among patients with type-II diabetes (Bruehl 
et al., 2007; Lee et al., 1999). Another interconnected consideration is that depression among older 
adults is associated with increased cortisol levels and memory impairments (McAllister-Williams, 
Ferrier, & Young, 1998), as well as increased risk for AD (Geerlings, den Heijer, Koudstaal, 
Hofman, & Breteler, 2008; Ownby, Crocco, Acevedo, John, & Loewenstein, 2006). Moreover, 
reductions in HV are found among older patients diagnosed with depression (O'Brien, Lloyd, 
McKeith, Gholkar, & Ferrier, 2004; Steffens et al., 2000). Interestingly, evidence from elderly 
twins shows that genetics can only account for 40% of HV variance, whereas the other 60% are 
attributable to environmental factors that may exert an impact during different stages of one’s 
lifespan (Sullivan, Pfefferbaum, Swan, & Carmelli, 2001). These findings highlight the 
significance of factors related to the environment as well as AL for determining HV and 
functioning (McEwen, 2003c) and one’s subsequent risk of dementia and/or cognitive decline.  
Although the hippocampus is a sensitive brain region, it also has the capacity to adapt, 
protect, and renew itself against damage and AL via structural plasticity and neurogenesis in the 
dentate gyrus throughout adulthood (McEwen, 2001, 2002c). Indeed, a variety of pharmacological 
and behavioral factors have the capacity to protect the hippocampus. For example, physical 
exercise is associated with increased neurogenesis (Olson, Eadie, Ernst, & Christie, 2006), larger 
HV and improved memory performance (Erickson et al., 2009), as well as enhanced executive 
functioning (Baker et al., 2010; Colcombe, Kramer, McAuley, Erickson, & Scalf, 2004; Etgen et 
al., 2010; Kramer et al., 1999). Even under conditions of chronic stress, hippocampal atrophy and 
associated cognitive impairments can be reversed following the use of appropriate treatments 
(Duman, Nakagawa, & Malberg, 2001; Vermetten, Vythilingam, Southwick, Charney, & 
Bremner, 2003; Vythilingam et al., 2004). Despite the vulnerability of the hippocampus to various 
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toxic effects, it is remarkably resilient when modulated by factors that also contribute to reducing 
AL (McEwen, 2008; McEwen, de Leon, Lupien, & Meaney, 1999). In this view, one can envision 
the brain itself as undergoing a form of allostasis via its plasticity under different circumstances. 
 
Conclusions and future directions 
 Taken together, there is substantial evidence that biomarkers included in the AL model are 
associated with dementia, albeit we are far from knowing the exact biopsychsocial signatures of 
dementia’s different faces. While this claim is based largely on MetS and vascular parameters of 
the AL index, several methodological considerations should be addressed given the diverse 
findings. Most importantly, the biomarkers incorporated in the AL construct depend largely on the 
participants’ age and sex. For instance, some evidence suggests that cortisol and noradrenalin in 
men may be associated with future cognitive decline, while other studies indicate that cortisol 
might be protective in individuals with MCI. Secondly, the paucity of research using 
neuroendocrine and inflammatory biomarkers in relation to cognitive decline and neurotoxicity in 
relation to dementia limits any conclusions at this time. Finally, the prospective studies cited 
above all used different methodologies and inclusions of covariates (e.g., education, medication) 
that are not fully understood in relation to dementia. Furthermore, the role of neurological 
degeneration as in the case of hippocampal vulnerability should be explored further in 
transdisciplinary studies that incorporate AL biomarkers, brain imaging, and various other 
methodologies. Consistent with a developmental perspective, tracking whether certain clusters of 
vulnerabilities manifest themselves necessitate longitudinal investigations.  
 An important avenue for future research would be to demarcate in greater detail the 
sequence whereby AL mediators lead to primary effects that include oxidative stress (McEwen, 
2008). Defined as a state of increased free radical production relative to antioxidant defenses, 
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oxidative stress has been related to damage of several sub-cellular structures. For example, normal 
aging is associated with a slow progressive accumulation of oxidative damage (Wallace, 2005), 
but this phenomenon may be accelerated in brains of individuals suffering from neurodegenerative 
disorders (Mariani, Polidori, Cherubini, & Mecocci, 2005). Disturbances in oxidative stress 
metabolism may therefore contribute to the development of secondary and tertiary outcomes of 
AL, representing a molecular primary effect. Another important question that remains to be 
addressed is whether hormonal signals (e.g., cortisol, DHEA) and inflammatory markers (e.g., IL-
6, CRP) influence global health outcomes when elevated in the context of existing systemic 
imbalances such as metabolic syndrome, pathological aging, or in the context of special behaviors 
and social situations. One elusive social situation that combines a special set of behaviors and 
psychological challenges is caregiving. Our final section will explore caregiving as a unique 
experiment of nature whereby individuals are at risk of increased AL by virtue of their altruism. 
 
The Stress and Strain of Caregiving 
Stress associated with caring for an elderly or mentally ill person can adversely affect the 
health status of caregivers. Although some caregivers are able to cope well with their role and 
experience few symptoms of distress along with a positive gain from the experience (Kramer, 
1997; Schulz et al., 1997), growing bodies of literature document the stressful nature and health 
risks of being a caregiver. According to the National Alliance of Caregivers, an estimated 43 
million Americans, over the age of twenty, function as informal caregivers providing unpaid care 
to older ill or disabled family member or friends as well as collectively saving the formal health 
care system billions of dollars annually (Ory, Hoffman, Yee, Tennstedt, & Schulz, 1999). 
Unfortunately, caregiving comes at a personal price as a chronic stressor (Bookwala & Schulz, 
2000; Vitaliano, 1993), thus representing a human model of chronic stress (Lupien et al., 2009). 
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This section will correspondingly review the negative health outcomes of caregiving and studies 
that examine the psychological, physical, physiological, and social consequences of caregiving 
that are demonstrably related to increased AL.  
 
Psychological outcomes of caregiving 
 Caregivers demonstrate higher levels of psychological distress as well as symptoms of 
depression and anxiety (Schulz, O'Brien, Bookwala, & Fleissner, 1995; Schulz, Visintainer, & 
Williamson, 1990). The inherently stressful nature of being a caregiver has been tested in several 
studies revealing the effects of AL. In a study on AD caregivers by von Känel and coworkers 
(2003), a greater number of negative life events related to increased AL levels based on more 
pronounced procoagulability responses to a 15-minute speech task was found. This unique finding 
suggests that high baseline AL (combined caregiving and life distress) is linked to a reduced 
ability for the caregivers to maintain hemostatic stability in response to a laboratory stressor (von 
Kanel, Dimsdale, Patterson, & Grant, 2003). In another AL study mentioned earlier, the stress of 
providing care was tested in mothers of children with cancer and controls. Results showed that 
increased AL was associated with intensified post-traumatic stress disorder symptoms (Glover, 
2006) and smaller right HV (Glover et al., 2008). 
 In addition to psychological effects, diminished cognitive function and general emotional 
distress also result from caring for a relative with a mental illness. In one of the few studies on 
caregiver stress and cognitive function, women who provided care to their ill spouses were found 
to have significantly increased risk of low cognitive functioning on several cognitive tests when 
compared to women who did not provide any care (Lee, Kawachi, & Grodstein, 2004). The 
psychological experience of caregivers also examines caregivers’ emotions and places their value 
system into question. For instance, self-conscious emotions (e.g., guilt and shame), general 
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emotional distress (GED), and expressed emotion (EE) in family members of patients with 
schizophrenia revealed that increasing shame proneness was strongly associated with greater 
caregiver distress, whereas increasing guilt proneness was associated with less distress. The results 
suggest that caregivers of patients with schizophrenia who are shame prone may be predisposed to 
view incidents, such as having a relative with a mental illness, as something that reflects 
negatively upon themselves.  Consequently, they may be more likely to experience high levels of 
the type of GED tapped by the Depression and Anxiety Stress Scale (de Mamani, 2010), shame, 
and social isolation.  
 Conversely, guilt proneness is associated with lower levels of GED. Guilt proneness may 
be associated with a certain level of interpersonal problem-solving in caregivers of schizophrenia 
patients that directly or indirectly lowers GED.  For instance, guilt proneness may encourage 
relatives to make amends after being aggravated with a patient, or to try to assist an ill relative that 
one has recently shunned (de Mamani, 2010).  This implies the potential therapeutic value of 
evaluating caregivers’ guilt proneness to help identify individuals who may be at particularly high 
risk of experiencing psychiatric symptoms. Likewise, these findings suggest that clinicians should 
be cautious of attempting to lessen or eliminate caregivers’ guilt that is associated with caring for 
a loved one with a mental disorder. Rather, assisting family members to find productive strategies 
to direct their guilt, such as providing support, advice, or other types of assistance to the patient, 
while also caring for their own needs may prove beneficial.   
 More recently, researchers have focused not only on providing care as a source of distress, 
but also on the caregiver’s perception of how much the patient is suffering. Patient suffering is 
evident in three related and measureable ways: overt physical signs, including verbal and 
nonverbal expression of pain and physical discomfort, such as difficulty breathing; psychological 
symptoms of distress, such as depression and apathy; and existential or spiritual well-being, 
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reflecting the extent to which religious or philosophical beliefs provide inner harmony, comfort 
and strength, or alternately, lead to despair (McClain, Rosenfeld, & Breitbart, 2003; Schulz et al., 
2007). Specifically, it has been shown that two types of patient suffering – emotional and 
existential distress – are significantly associated with caregiver depression and use of 
antidepressant medication (Schulz et al., 2008). Emerging evidence of this nature demonstrate the 
transdisciplinary assessment of factors such as the level of patient suffering, since they may 
contribute substantially. 
 
Physiological outcomes of caregiving 
 Caregiver stress has been linked to adverse physiological health in a large number of 
studies. Specifically, elevated blood pressure (King, 1992; Moritz, 1992), heightened 
cardiovascular reactivity (Vitaliano, 1993), risk for coronary heart disease (Haley, Roth, Howard, 
& Safford), elevated cortisol levels (de Vugt et al., 2005), lower immune function (Kiecolt-Glaser, 
Dura, Speicher, Trask, & Glaser, 1991), and even increased mortality among spousal caregivers 
(Schulz & Beach, 1999) have been observed.  
 With regards to the effects of chronic stress on GCs, one study in particular assessed 
caregivers who had elevated diurnal cortisol levels and tended to be older caregivers of patients 
with AD (de Vugt et al., 2005). Similar effects have been observed in a 7-day study of younger 
caregiving wives of patients with physical problems whereby caregivers had higher cortisol 
production when particular events related to caregiving occurred in comparison to controls (Davis 
et al., 2004). These findings provide evidence that psychological changes are indictors of chronic 
stress in caregivers and potentially brewing AL.  
 Further physiological effects of caregiving are apparent in a more recent study on the 
impact of caregiving strain and the risk for stroke and coronary heart disease among spousal 
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caregivers. Results demonstrated that high caregiving strain was associated with higher estimated 
stroke risk with greatest effects for African American men providing care to their wives (Haley et 
al.). As well, a cohort study reported an almost twofold increase in risk of coronary heart disease 
in women who provide care to a disabled or ill spouse for 9 or more hours per week (Lee, Colditz, 
Berkman, & Kawachi, 2003). Regardless of the caregivers’ sex, the stress of providing care can 
be, in itself, a risk factor for stroke and coronary heart disease. It is important to note that women 
are often caregivers, and as such this represents a gender-role assignment that should be 
investigated further. Additionally, applying a developmental analysis that takes previous 
experiences in the lifespan into consideration could be helpful.  
 Ultimately, the immense stress and strain of caregiving impinges on caregivers’ 
physiological functioning and increases their risk for physical health problems, leading even to 
premature mortality. In an edifying study, caregiving has been identified as an independent risk 
factor for death with increased risk in individuals experiencing caregiver strain over a 4-year 
period (Schulz & Beach, 1999). Perceived stress has also been related to higher AL primary 
mediators in veteran dementia caregivers over two years in comparison to new and non-caregivers 
(Clark, Bond, & Hecker, 2007). Collectively, these studies demonstrate that caregivers are at 
increased risk of mortality and ill health.  
 
Physical outcomes of caregiving 
 The chronic stress of caregiving affects numerous dimensions of caregiver health, 
including self-reported health, health symptoms, illness and medication use (Asada, Kinoshita, & 
Kakuma, 2000; Cacioppo et al., 1998; Schulz & Beach, 1999; Vitaliano, Zhang, & Scanlan, 2003; 
Zhang, Vitaliano, & Lin, 2006). A revealing study has shown that caregivers experience a one-
third increase in negative health symptoms after assuming caregiving responsibilities (Shanks-
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McElroy & Strobino, 2001). Spousal caregivers also report an increase in days ill due to infectious 
disease, primarily upper respiratory tract infections (Esterling, Kiecolt-Glaser, & Glaser, 1996). 
Results on caregiving stress and caregiver’s functional ability indicate that caregivers who report 
higher levels of caregiving stress have poorer self-rated health, poorer physical function, more 
symptoms and high levels of depressed mood (Lu & Wykle, 2007). Caregivers are also increased 
consumers of prescription medications (Schulz et al., 1997). 
  Self-care is often compromised as caregivers provide a high level of care for others. 
Common complaints include forgetting to take medications, having no time to exercise, nor see a 
doctor or rest when ill, and finally insomnia (Burton, Newsom, Schulz, Hirsch, & German, 1997; 
Schulz et al., 1997). Several studies report sleep problems as a major adverse physical outcome of 
caregiving (Creese, Bedard, Brazil, & Chambers, 2008; Flaskerud, Carter, & Lee, 2000; Matsuda, 
Hasebe, Ikehara, Futatsuya, & Akahane, 1997; McKibbin et al., 2005; Meltzer & Mindell, 2006; 
Tsukasaki et al., 2006; Wilcox & King, 1999). These problems include nighttime or early morning 
waking, difficulties in sleep onset, poor sleep quality, less slow-wave sleep, insomnia, and most 
commonly, sleep disruptions (Flaskerud et al., 2000; Matsuda et al., 1997; Tsukasaki et al., 2006; 
Wilcox & King, 1999).   
 Sleep disruptions are a risk factor for poor mental health among caregivers and this has 
been well documented. Specifically, studies have reported that the quality of sleep is significantly 
associated with depression among caregivers of cancer patients as well as patients with AD 
(Carter & Chang, 2000; Willette-Murphy, Todero, & Yeaworth, 2006).  In a similar vein, 
caregivers whose sleep was frequently disrupted were about 2.5 times more likely to suffer from 
poor mental health, compared to those whose sleep was not disrupted (Lam, 2008). Sleep is an 
essential and yet empirically unexplored component of the AL model (McEwen, 2006b) that 
should be explored in caregivers and other adverse conditions. Indeed, aberrations in sleep are 
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associated to numerous biomarkers associated to secondary outcomes of AL (Copinschi et al., 
2010; Knutson, Spiegel, Penev, & Van Cauter, 2007; Knutson et al., 2009; Spiegel, Tasali, Penev, 
& Van Cauter, 2004; Tasali, Leproult, Ehrmann, & Van Cauter, 2008; Van Cauter et al., 2007).  
 
Conclusion and future directions 
 The literature on caregivers clearly indicates that the intensity of chronic caregiving is 
associated with a multitude of health issues. From the psychological strains of providing care, to 
the physical toll and social stigma identified with caring for a mentally ill relative, the caregiving 
experience places a cumulative toll on the mind and body, contributing to increased AL and 
consequent morbidity and premature mortality. This is an example of complex dynamic 
interactions between behavior (caring for a relative), psychological issues (shame and guilt, 
general emotional distress), physiological outcomes (allostatic mechanisms), and social factors 
(social stigma or supporting environment) that collectively, through their interaction, exert 
powerful influence over important clinical outcomes. 
 The future direction of caregiver strain research could be to integrate multiple biomarkers 
to assess AL in caregivers as van Känel’s group did looking at multiple dynamic biomarkers. This 
would reinforce the continued study of caregiving outcomes that tend to only focus on single 
biomarkers, if at all, and fall short of addressing effects on multiple physiological systems, or the 
downstream effects on physical or cognitive health debility. As higher AL is associated with poor 
health outcomes, undertaking various perspectives may help us better understand and implement 
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General Conclusion 
 In order for the AL model to evolve from a research index into a clinical tool, it must 
become accessible for healthcare providers such as physicians, psychiatrists, and auxiliary 
professionals. Research has clearly substantiated that the AL index is sensitive to a wide array of 
stress-related conditions, and yet there is a perplexing reluctance to apply the AL model in 
practice and even more so as it relates to psychopathology. How could physiological algorithms 
possibly apply when testing and treating psychiatric patients? We hope that this review article is a 
rejoinder to this skepticism, as we believe strongly in the utility of an AL index in conjunction to 
interdisciplinary methodologies (e.g., combinations of psychosocial questionnaires, genetic 
assessment, routine physical check-ups, neuropsychological testing, clinical interviews, etc.) will 
facilitate person-centered approaches to research and practice alike. Furthermore, such 
biopsychosocial AL batteries could be used to comprehensively investigate the efficacies of 
interventions at multiple levels.  
 There are critical periods whereby the health sciences can identify individuals earlier on 
before AL leads to tertiary outcomes. This assertion stems from a population-based analysis of 
NHANES using more than twenty-two thousand participants, where it was shown that AL steadily 
increases with age up through the 20s to 60s and then plateaus throughout the 60s to 90s during 
the period of greatest mortality risk (Crimmins, Johnston, Hayward, & Seeman, 2003). From life 
cycle and AL perspectives, this represents decade-long windows of opportunity to intervene 
before individuals succumb to disease and death; more than enough time to enact and instill 
positive health. 
 Because living with certain health conditions (e.g., severe mental illness, dementia, 
caregiving) can increase AL levels further, we believe the AL index could additionally be an 
effective tool to monitor disease courses and emergence of comorbidities.  Even if most studies 
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focus on physical outcomes, mortality rates, and the psychosocial antecedents of increased AL, the 
AL index shows tremendous promise in the study of psychopathological states as well. Just at a 
theoretical level, literature linking AL composites to psychopathologies like mood disorders 
(Kapczinski et al., 2008; McEwen, 2003c, 2004, 2005), anxiety disorders (McEwen, 2002b; 
Schulkin, Gold, & McEwen, 1998; Schulkin, McEwen, & Gold, 1994), and substance abuse 
(Koob, 2003; Koob et al., 2004; Koob & Le Moal, 2001; Schulkin, 2003a; Valdez & Koob, 2004) 
are very comprehensive, but unfortunately rarely applied to human studies.  
 A key theme emerging from the literature on psychopathology reviewed here is 
interaction. There are indeed complex interactions of hormones and biomarkers with 
neurophysiological systems and structures; constant interactions between biological systems; and 
profound interactions of biological, psychological, social, behavioral, and spiritual factors at the 
individual level. We have shown here that situations of early adversity, genetic and epigenetic 
elements, exposure to environmental toxins, sex and gender-related factors, and the experience of 
caregiving can in synergy exact profound influences on psychopathological outcomes. Guided by 
a developmental psychopathological approach (Cicchetti & Rogosch, 2001; Cichetti & Toth, 
2009; Rutter & Sroufe, 2000), we have also outlined the multidimensional implications of specific 
psychopathologies such as bipolar disorder, schizophrenia and the dementia spectrum as models 
of AL. A critical point to recognize is that these factors, which are directly or indirectly related to 
the individual, interact in complex ways to influence life-long disease susceptibilities. 
Understanding the nature and dynamics of these interactions, along with their impact on 
individual’s psychological health require transdisciplinary approaches that include a broader 
analysis of the individual within society (Picard et al., 2011). 
 Beyond interaction, a transdisciplinary approach to AL also resembles transactional 
models previously outlined due to the bi-directional nature of the antecedents and the spectrum of 
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consequences associated with chronic stress. Take for instance the central propositions of 
Bronfenbrenner’s general ecological model whereby individual development is shaped by 
complex reciprocally interacting systems (Bronfenbrenner, 1977, 1994, 1995). These 
interdependent forces consist of the individual’s immediate environment (micro-system), the 
interconnections among several individuals (meso-systems), the indirect influence of social 
structures and settings (exo-system), and finally the current overarching cultural and sub-cultural 
patterns (macro-system) over time (chrono-system). Consistent with the current review, we state 
that AL is clearly associated with SES, social/relationship, workplace, lifestyle, race/ethnic, and 
genetic factors throughout lifespan development. Targeting these antecedents of AL during key 
periods of development is therefore essential to improving public health. As such, our proposal of 
a trandisciplinary AL model shares similarities with transactional models already espoused in the 
field of developmental psychopathology (Sameroff, 2009; Sameroff, 2000; Sameroff & 
Mackenzie, 2003).  
 Applying transdisciplinarity to psychopathology necessarily involves the creation of new 
knowledge emerging from the space between and beyond academic disciplines (see Figure 7). 
Disciplinary pillars must serve as solid foundations for an integrative process of inquiry directed at 
complex health problems. Research questions guided by real-life problems rather than determined 
by specialized disciplinary tools and perspectives and methodologies must be formulated. 
Establishing such transdisciplinary problems necessarily spanning multiple areas of research is the 
key consolidating ingredient to fruitful transdisciplinary research, rallying researchers towards 
sharing a common scientific objective (Kessel et al., 2008). Importantly, major funding agencies 
have recognized the need and the special challenges of multiple-investigator projects; as a result, 
several new interdisciplinary funding programs now exist (Kessel & Rosenfield, 2008). For the 
field of psychopathology, adopting transdisciplinary research perspectives should allow 
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researchers to integrate available evidence originating from multiple disciplines. Ultimately, one 
must position the individual and her/his complex transactional and multi-level experiences at the 
heart of scientific enquiry. 
In conclusion, the AL model offers a useful framework for disciplines to come together 
with a common objective to impact individual’s health. We believe that the AL model has 
potential to assist the progression towards transdisciplinary approaches to research, health care, 
and prevention for psychopathology throughout lifespan development. 
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